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Abstract 
Conscious sedation or moderate sedation and analgesia is an effective and  
popular alternative option for procedures outside the operating theater.  If 
conscious sedation is a viable alternative to general anaesthesia then we as 
sedation practitioners must use safe sedation techniques in facilities that meet all 
the requirements for safe practice.  
Three studies were done to determine the safety and efficacy of conscious 
sedation outside the operating theatre.  In the first study post sedation satisfaction 
in one hundred children aged 3-9 years was evaluated.  It was extremely important 
to determine whether the combination of midazolam, ketamine and propofol, 
called an advanced sedation technique (SASA, 2015), can be safely used for 
paediatric sedation outside the operating theatre.  The incidence of  side-effects 
after conscious sedation using multiple drugs were documented.  It is clear that 
intravenous sedation with midazolam, ketamine and propofol is safe and effective 
to use.  There may be side effects but they are not long lasting and usually not 
life-threatening. 
 
In the second study intravenous sedation was administered to 447 adults (aged 
18 years and older) using fentanyl (sublimazeR), ketamine (ketalar), midazolam 
(dormicum) and propofol (Diprivan) (FKMP) called an advanced sedation 
technique.  Post sedation satisfaction, post sedation recovery on arrival home, and 
the relationship between side effects and different dental procedures were 
evaluated.  The results of the study show that side effects are possible, and can be 
expected, when we use sedative and analgesic drugs for sedation.  However, we 
report a low incidence of side effects when we compare it with other studies in 
literature as mentioned.  It is known that the use of combinations of drugs may 
cause unforeseen synergistic pharmacological effects which can be life-
threatening.  Our results show that the drugs used can be safely used for advanced 
sedation techniques. 
 
In trying to demonstrate the safety of sedative and analgesic agents used during 
sedation we looked at the haemodynamic parameters, duration of sedation, pulse 
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rate and systolic blood pressure, in the third study.  The sedation records of 335 
patients for dental surgery were assessed for the period 2010 – 2011.  Our results 
show the mean Duration of sedation is substantially and statistically significantly 
greater with combination FKMP than with the other combinations.  The mean 
duration of sedation is not significantly different between ketamine and propofol 
(KP) and fentanyl, ketamine and propofol (FKP) (Figure 10). 
 
The use of polypharmacy regarding the combination of drugs, specifically FKMP, 
will cause a longer duration of sedation.  This has implications for safety, as well 
as the side effect profile during and after sedation.  When we use combinations of 
drugs patients were more comfortable which shows that we do not yet have a 
single drug that has all the characteristics of an ideal drug for sedation.  Different 
combinations of drugs are used by other practitioners with a higher incidence of 
side effects.  It is difficult to explain the higher values of blood pressures when all 
four drugs were used.  It may have been a ketamine effect, although one would 
not expect this when using propofol with ketamine.  In clinical terms the higher 
blood pressures are no reason for concern as all our patients were classified as 
ASA I and II.  
 
Our research study support the view that ketamine can be used safely outside the 
operating theatre with exciting possibilities for Third World countries for 
procedures outside the operating theatre.  Sedation can be considered a reasonable 
alternative to general anaesthesia for certain surgical procedures in the Third 
World.  Sedation will be an attractive option not only as far as costs are involved 
but also the availability of sedation providers.  The important lesson from all the 
results is that sedation providers must be trained in procedural sedation as defined 
by all international sedation guidelines.  We proved in this research study that 
sedation can be done safely, however we need to make a contribution to train 
sedation providers. 
 
Sedation will become an attractive alternative to general anaesthesia because of 
the low side-effect profile and high patient satisfaction.  It is interesting that few 
studies are available that looked at this aspect of sedation.  It is clear that a high 
side-effect profile can contribute to an unsafe sedation technique.  Severe nausea 
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and vomiting can cause numerous haemodynamic disturbances and dehydration.  
Our research study support the findings of the study by Lapere et al., (2015) that 
there is a high rate of patient satisfaction, and a low side-effect profile during and 
after sedation. 
 
This is an extremely important research study and the results are crucial as far as 
an option for healthcare in developing countries.  Sub-Saharan Africa is a densely 
populated and resource poor subcontinent that provides unique challenges in 
patient care.  These challenges include a lack of facilities and staff for the 
performance of operative as well as non-operative procedures.  
 
In conclusion, we feel that we are part of Sub-Saharan Africa with all the 
problems mentioned as far as provision of healthcare is concerned.  This research 
study can make a crucial contribution to safe and cost-effective management of 
healthcare in Africa for procedures outside the operating theatre. 
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CHAPTER 1: SCOPE OF THESIS  
 
This thesis evaluates the management of a sedation unit outside the operating 
theatres with a view to monitor the safety of patients.  
The literature review in Chapter 3 gives a broad overview of the safety and cost 
effectiveness of a sedation unit.  
 
The three studies reported in Chapter 4 look respectively at, the experience of 
children and parents during the post sedation recovery process, on the journey 
home and at home.  Post sedation satisfaction in adults and haemodynamic 
effects of drugs were evaluated. 
 
The incidence of adverse events during and after dental procedures done under 
sedation is evaluated.  The safety and efficacy of sedative and analgesic drugs 
in adults and children during conscious sedation, which is of prime concern for 
the sedation practitioner, is examined. 
 
Conclusions are  reported in Chapter 5  
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CHAPTER 2: INTRODUCTION  
 
Pain, anxiety and fear are often synonymous in the minds of patients when they 
go for dentistry.  Quite a number of dental procedures can cause pain and 
pressure, even when local anaesthesia is used.  It is claimed that 7-15% of adults 
(Yagiela, 2001) in the USA are very nervous or terrified about having to receive 
dental care, in children this incidence is reported as 24%.  This may lead to 
patients ignoring dental care because of the anxiety towards possible dental 
procedures.  This may be detrimental to the health of patients.  
 
Anxiety and fear, and the possibility of pain, towards a sometimes unknown 
surgical procedure may lead to emotional stress for the patient, varying from 
suppressed fear of pain, and other stress related symptoms to a phobia which can 
make dental treatment impossible.  Patients may even show physical signs of 
increased sympathetic stimulation such as sweating, hypertension, tachycardia, 
and tremors.  These symptoms and signs may lead to anxiety-induced cardiac 
arrhythmias, hypertension, cerebrovascular accidents, and/or vaso-vagal reactions, 
especially in the medically compromised patient.  
 
In children, studies (Kain  et al., 1996) indicate that some of the above-mentioned 
symptoms and signs can lead to an increased incidence of postoperative 
behavioural symptoms e.g. agitation, restlessness – the frequency may be as high 
as 60%.  It is reasonable to say that any patient has the right to effective pain and 
anxiety control, and it is the duty of the doctor or dentist to provide this.  The 
benefits of relieving fear, anxiety and pain in a patient are numerous.  It ensures a 
calm, cooperative, understanding patient who is able to tolerate an unpleasant 
procedure comfortably.  It may even lead to better dental care as the patient will 
visit the dentist for any dental problems. 
 
The question is what can we do to provide pain and anxiety control?  Conscious 
sedation or moderate sedation and analgesia can be an effective method of 
facilitating dental treatment and is often used as an option with local anaesthesia.  
Properly provided, by sedation practitioners who are trained to provide this, 
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sedation is safe, valuable and cost-effective for dental patients.  If conscious 
sedation is a viable option, consideration should be given to develop safe sedation 
practice in facilities outside the operating theatres. 
 
There are four possible treatment options available for patients undergoing 
dental surgery 
 Local anaesthesia as block / infiltration 
   A good option for the non-anxious, reasonably, cooperative patient. 
 Local anaesthesia block / infiltration with behaviour management 
techniques for the moderately anxious patient.  It is generally agreed that all 
anxious and uncooperative patients can and should be managed with 
behaviour management techniques, but it is not always practically possible.  
Children are an important group in this regard that should receive special 
attention. 
 General anaesthesia  
This is obviously the easiest way out but the question is, is it always the best 
option?  General anaesthesia is also not always available and the side-effect 
profile e.g. postoperative nausea and vomiting may be high and 
unacceptable to patients.  It is advisable to ask patients about their 
preferences.  It is known that the need for general anaesthesia for dental 
surgery in the UK has decreased with sedation techniques becoming 
available. In the UK and other countries general anaesthesia was an option 
outside the hospital for dental surgery. (GDC 2005)   Since 2012 this 
practice has been stopped.  The health departments in some countries e.g. 
the UK encourage dental patients to consider having dental procedures 
under sedation. 
 Local anaesthesia block / infiltration with conscious sedation. 
This has become an attractive option as patients can be treated in the dental 
surgery, and they can go home the same day of the operation.  It is also well 
known that the side effect profile is less than general anaesthesia. 
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DEFINITIONS, TERMINOLOGY AND SAFETY ASPECTS 
 
Attention must be paid to definitions and certain terminology that form part of 
quality control in safe sedation practice – giving guidance to those involved in 
sedation practice (SASA, 2015). 
 General anaesthesia is defined as a state of controlled unconsciousness.  
This is not our goal outside the operating theatre (Sá Rêgo, Watchy and 
White, 1997). 
 Analgesia is defined as the relief of pain without the intention to produce 
sedation.  Some of the analgesic agents for example, the opiates may have 
sedative effects.  An altered mental status may be a secondary effect of 
medications administered for this purpose (Sá Rêgo, Watchy and White, 
1997). 
 Local anaesthesia is defined as the elimination of sensation (with or without 
motor activity) in the body, by topical application, infiltration or local/ 
regional injection of local anaesthetic agents (Sá Rêgo, Watchy and White, 
1997). 
 Anxiolysis is a drug-induced state during which patients respond normally 
to verbal commands, often described as an alternation of mood.  Although 
cognitive function may be impaired, ventilatory and cardiovascular 
functions are unaffected.  The patient is fully conscious, usually calm and 
alert (Sá Rêgo, Watchy and White, 1997).The level of awareness usually 
does not change.  The state of anxiolysis has very important implications for 
monitoring, only clinical monitoring is considered necessary.  
 Conscious sedation or moderate sedation and analgesia is a 
pharmacologically induced, controlled, and minimally depressed level of 
consciousness.  Patients usually respond purposefully to verbal commands, 
either alone or accompanied by light tactile stimulation.  The patient usually 
maintains the ability to maintain his airway, and spontaneous breathing is 
adequate.  Cardiovascular function is maintained and vital signs remain 
stable.  If left undisturbed, the patient may fall asleep but is easily roused by 
auditory or tactile stimuli.  Protective reflexes, like coughing and 
swallowing, are intact (Sacchetti et al., 1994).  Guidelines exist for the safe 
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use of sedation for diagnostic, therapeutic and palliative procedures in 
adults  (South African Society of Anaesthesiologists, 2002).   
 With conscious sedation or moderate sedation and analgesia the airway is 
usually maintained.  
 It is important to note that the definition of conscious sedation by The 
General Dental Council’s (GDC,  2005) in the UK is somewhat different 
than other international sedation guidelines – if a patient is not responding to 
verbal commands, but only to physical stimulation, then the technique is not 
conscious sedation.  It is considered as light general anaesthesia.  
 Conscious sedation is defined as a technique in which the use of a drug or 
drugs produces a state of depression of the central nervous system enabling 
treatment to be carried out (Wylie Report, 1981), but during which verbal 
contact with the patient is maintained throughout the period of sedation.  The 
drugs and techniques used to provide conscious sedation for dental treatment 
should carry a margin of safety wide enough to render loss of consciousness 
unlikely (General Dental Council, 2005). 
 In the rest of the world conscious sedation is seen as a technique whereby 
the patient will respond to verbal contact and or mild physical stimulation.  
The GDC further states that it is of fundamental importance that the level of 
sedation must be such that the patient remains conscious, and is able both to 
understand and respond to verbal commands.  The definition also describes 
the state of conscious sedation, and does not attempt to prescribe how it 
should be achieved.  
 Procedural Sedation and Analgesia (PSA) is a definition that has become 
very important in sedation practice, is universally used, and needs to be 
mentioned. Some organizations believe that older terminology that includes 
the phrase conscious sedation should be abandoned as it does not really say 
anything about analgesia which is fundamental to the concept of sedation.  
Procedural sedation and analgesia (PSA) is a more appropriate and accurate 
description.  PSA should be viewed as a continuum ranging from light to 
deep sedation, with the depth of sedation easily titrated by selective 
administration of sedative and analgesic drugs (Evered, 2003).  PSA can 
thus mean either minimal sedation or moderate sedation, or deep sedation.  
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The problem we have with this definition is that the sedation practitioner has 
a license to operate at whatever level of sedation, including deep sedation – 
this could have an impact on the incidence of side effects.  The sedation 
practitioner must monitor his patient closely to prevent the patient slipping 
into deeper than intended levels of sedation. 
 Deep Sedation and Analgesia.  The definition needs to be clarified as many 
guidelines regard this level no different than general anaesthesia.  In the UK 
this level is seen as “light general anaesthesia” and patients should be done 
in a hospital environment.  Deep sedation is defined as a pharmacologically 
controlled induced state of depressed consciousness.  The patient is not 
easily aroused or roused by repeated stimulation.  The protective reflexes for 
example, coughing and swallowing may be lost.  The patient may not be able 
to respond purposefully to physical stimulation or verbal command.  To 
maintain a patent airway the airway may have to be supported by the 
sedation practitioner  (American Society of Anesthesiologists, 2000; SASA, 
2015). 
 
It is important to take note of the approach of the General Dental Council  (2005) 
on procedural sedation,  
“The level of sedation must be such that the patient remains conscious, 
retains protective reflexes, and is able to understand and respond to 
verbal commands. Deep sedation in which these criteria are not fulfilled 
must be regarded as light general anaesthesia.” 
 The GDC regards deep sedation as light general anaesthesia.  If deep 
sedation is planned it must be done in secondary care (in hospital) by an 
anaesthetist who had sedation training or a medical practitioner with 
equivalent experience in the administration of sedation. 
 General Anaesthesia:  A controlled, pharmacologically induced state of 
unconsciousness accompanied by complete loss of protective reflexes, 
including the inability to independently maintain an airway, and respond 
purposefully to physical stimulation or verbal command (American Society 
of Anesthesiologists, 2000). 
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The Joint Commission on the Accreditation of Healthcare Organisations 
(JCAHO) (American Society of Anesthesiologists, 2000) have introduced the new 
terminology just mentioned:   
 
 minimal sedation (anxiolysis),  
  moderate sedation and analgesia,   
 deep sedation and analgesia (the patient may require airway interventions)  
  General anaesthesia. 
 
The American Society of Anesthesiologists (2000), the updated 2015 South 
African Society of Anaesthesiologists Guidelines on Procedural Sedation and 
Analgesia, and almost all professional organizations on guidelines for sedation 
worldwide, use the following definitions of sedation levels to give clarity to the 
continuum of sedation; 
 
Minimal sedation is a drug-induced state during which patients respond 
normally to verbal commands.  Although cognitive functions and 
coordination may be impaired, pulmonary and cardiovascular functions 
are unaffected.  Only clinical monitoring is needed to look after the 
patient during sedation. 
 
Moderate sedation and analgesia,  also called conscious sedation, is 
defined as a drug induced depression of consciousness during which the 
patient responds purposefully to verbal commands (General Dental 
Council,  2005), either alone or with light, tactile stimulation.  No 
interventions are usually required to maintain a patent airway and 
spontaneous ventilation is adequate.  Cardiovascular function is usually 
maintained. 
 
Deep sedation is a drug-induced depression of consciousness during 
which patients cannot be easily aroused but respond purposefully 
following repeated painful stimulation.  The ability to maintain 
pulmonary function independently may be impaired.  Patients may 
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require assistance in maintaining a patent airway, and spontaneous 
ventilation may be impaired. 
 
According to UK guidelines on sedation the patient must respond to verbal 
command to meet the requirements of conscious sedation.  When the patient has 
to be touched, or lightly stimulated to get a response this is not conscious sedation 
anymore. According to the Wylie report, the drugs and techniques used to provide 
conscious sedation for dental treatment should carry a margin of safety wide 
enough to render loss of consciousness unlikely.  This definition was originally 
proposed in the Wylie Report (1981) and the core of it has been adopted by the 
General Dental Council (UK), the Department of Health (UK), and the Society for 
the Advancement of Anaesthesia in Dentistry (UK), the Dental Sedation Teachers 
Group (UK), the South African Dental Association, and the British Society of 
Gastroenterology.  
 
Several definitions from different professional organizations and interest groups 
(Berggren and Meynert, 1984; Committee on Drugs of American Academy of 
Pediatrics. 1992;   Coté, 1994;  Holzman et al., 1994;  Oei-Lim, 1997;  Whitwam 
and Mccloy, 1998;  Lee,  Vann  and Roberts,   2001;  Jackson and Johnson, 2002;  
South African Society of Anaesthesiologists, 2002; Scottish Intercollegiate 
Guidelines Network, 2002;  Boidin, Wolff and Doelman,  2002; Department of 
Health, 2003 and Hallonsten et al., 2003;)  share the same core elements as 
described by the term conscious sedation as stated in the Wylie Report’s 
definition of 1981.  The core elements are ‘maintain a patent airway’ and ‘respond 
appropriately to physical stimulation. 
 
In the 2015 SASA guidelines on Procedural Sedation and Analgesia, the term 
conscious sedation is not used.  The term moderate sedation and analgesia, which 
is more descriptive, has replaced conscious sedation.  The term conscious sedation 
has become more or less obsolete in many countries as it is argued that this is not 
an accurate description of what sedation is.  Whatever the level of sedation it is 
extremely important for sedation practitioners to be able to recognise it. 
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A question often asked is, which is the safest: sedation or general anaesthesia? 
There are very few studies, if any, in literature available that compare the two 
techniques.  Providing high standards are maintained, and suitable trained people 
are available, both methods are probably equally safe.  However, high standards 
depend upon the quality, training, experience, facilities, guidelines and 
commitment of those involved.  To meet the requirements of safe sedation 
practice can be found in the 2015 SASA Guidelines on Procedural Sedation and 
Analgesia, and other international guidelines on safe sedation practice (SASA, 
2015). 
 
A question that is more relevant, do we have the manpower to meet the demands 
of the patient population for surgical procedures?  We can offer general 
anaesthesia in-hospital, and sedation outside the hospital for certain procedures. 
 
Large hospitals may have enough experienced doctors and nurses to run a safe 
sedation service but smaller hospitals probably do not have this luxury.  Safety of 
conscious sedation outside of the operating theatre (procedural sedation) in South 
Africa and worldwide is of prime concern for sedation practitioners.  At the 
Faculty of Dentistry,  University of the Western Cape,  Cape Town no 
morbidity/mortality has been reported during the last ten years of outside the 
operating theatre conscious sedation.  This is very encouraging in our search for 
safety and efficacy in sedation practice. 
 
Coplans and Curson (1982) were probably the first practitioners that published on 
sedation adverse events with parenteral conscious sedation.  There were no deaths 
in over two million sedations from 1970 to 1979.  Two fatalities were associated 
with conscious sedation from 1980 to 1989.  This shows that clinicians were 
worried about the incidence of adverse events even many years in the past, but 
that the incidence of serious adverse events was very low. 
 
In July 2000, an expert group of dental practitioners was convened by the Society 
for the Advancement of Anaesthesia in Dentistry (SAAD), the biggest 
organisation for conscious sedation in dentistry in the U.K.  Their aims were to 
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consider safe standards for conscious sedation in dentistry.  This document aimed 
to identify good clinical practice, which is appropriate and necessary for public 
and private patients within and outside hospitals.  The recommendations help 
sedation practitioners to attain and maintain high clinical standards.  In South 
Africa, the South African Dental Association (SADA) convened an expert group 
of representatives from the medical and dental profession to consider standards 
for safe conscious sedation in South Africa.  Guidelines were drawn up 
concerning safe sedation practice and the need for a dedicated facility where 
doctors/ dentists could be trained (Ad Hoc Committee of SADA, 2001). 
In a newsletter in the year 2000 the American Society of Anesthesiologists (ASA) 
predicted that by the year 2005, 85% of all operations will be done on an 
outpatient basis – 25% will be done in the office (Yagiela, 2001).  With this 
expected increase in operations outside the operating theatre there is a need to 
plan for sedation units that meet the demands for safe sedation practice.  
 
In the year 2010 South African Society of Anaesthesiologists (SASA) published 
separate sedation guidelines for children and adults.  This is a guide for safe 
sedation practice.  The guidelines were updated in 2015 (SASA, 2015).  The 
guidelines give a clear guidance to safe sedation practice. 
 
The growth and popularity of ambulatory anaesthesia and sedation in medicine is 
probably due to the cost-effectiveness and safety of the procedures  (Yagiela, 
2001).  Although the monetary savings behind this trend are obvious, the same 
cannot probably be said for dentistry.  Most non-invasive medical procedures are 
not repeated in the same patient.  In contrast, many dental procedures such as 
tooth scaling and operative restorations, which can be uncomfortable, are 
performed on multiple occasions for the same patient.  The choice here is either 
providing conscious sedation (or other forms of pharmacologic management) 
repeatedly or equipping the patient with the coping skills necessary to manage 
fear and apprehension.  For the patient, the most cost-effective strategy is to 
overcome the mental barriers preventing routine dental care.  Current procedure-
based economics for the dentist strongly favours pharmaco-sedation (Sacchetti et 
al, 1994).  
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Medical insurance and the government are extremely interested in the option of 
sedation as economic factors and patient satisfaction begin to play a significant 
role in medical and dental care.  General anaesthesia, when available, is expensive 
because of the costs of health care in hospitals. 
Conscious sedation administered outside a theatre environment, is one important 
option for patients to get the necessary, safe, and affordable dental care.  It is 
effective in reducing apprehension and pain and can improve patient behaviour 
without adversely affecting the patient’s physiological status.  Mortality and 
serious morbidity are exceedingly rare in modern practice.  Although behavioural 
strategies are clearly more cost–effective for the patient receiving routine dental 
care, in-office sedation is usually the least expensive alternative for patients 
requiring pharmacological management (Yagiela, 2001). 
 
Although general anaesthesia is safe, highly effective and reliable, it is becoming 
less relevant, for various reasons, in especially the dentists’ armamentarium – one 
reason being the cost demands of medical and dental insurance, placing its 
availability at a premium.  This is especially true in areas without traditional 
operating theatres.  With the previous as background, it would make sense to look 
at an option other than general anaesthesia.  Such an option has to be safe, 
acceptable to the patient, cost-effective, with preferably fewer side effects.   
 
It is believed that conscious sedation for dental surgical procedures, as an 
alternative for general anaesthesia, will become more and more important as many 
dental procedures can be done under conscious sedation outside the hospital 
environment.  This makes it a very attractive option for patients.  The therapeutic 
goal of sedation is to provide a calm, comfortable patient without pain, and 
cooperation when undergoing a procedure that often evokes anxiety, 
discomfort, and pain, but which may require full patient cooperation.  This is 
possible with conscious sedation. 
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CHAPTER 3: LITERATURE REVIEW 
 
3.1 Historical aspects of Procedural Sedation and Inhalation 
Sedation 
 
The beginning of sedation from a historical point of view is not very clear.  There 
is a reference to opiates on a Sumerian tablet about 4000 before Christ.  The 
Egyptian Papyrus Ebers (1500BC) quotes a remedy for “excessive crying in 
children” and the use of alcohol as a narcoleptic is mentioned in the old testament 
of the Bible (Cornwell and Cornwell, 1993).  Modern sedation, has developed 
over the last hundred years. 
 
In the preceding century the practice of anaesthesia was established and 
popularized.  This followed the discovery of nitrous oxide by Joseph Priestley in 
1776 who himself described the effects as “a highly pleasurable thrilling” 
(Edmund and Boyle, 1934).  Twenty years later Humphry Davy (Fujita, 1998)    
noted the analgesic properties of nitrous oxide and suggested that it would be 
suitable for use as an analgesic in surgical procedures.  His proposal was largely 
ignored until Horace Wells (Haridas, 2013), a dental surgeon used nitrous oxide 
inhalation to extract a tooth.  
 
The incremental technique of Drummond-Jackson using (Gopakumar and 
Gopakumar, 2011) intravenous hexobarbitone was probably, a controversial way 
of controlling pain in dentistry.  He pioneered the technique to produce a 
controlled level of consciousness by using increments of hexobarbitone via the 
intravenous route (Holden, 1983).   
 
Niels Bjorn Jorgensen (1966) is often considered as the father of intravenous 
sedation in dentistry.  In 1945, he and Leffingwell, anaesthesiologist at Loma 
Linda University, researched possible ways of relieving fear and anxiety in 
ambulatory patients receiving dental care under local anaesthesia.  Jorgensen 
became probably the first person to use the intravenous route for administration of 
a combination of intravenous pentobarbitone, pethidine and hyocine as 
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premedication in patients prior to undergoing long dental procedures (Holden, 
1983).  Jorgensen demonstrated the safety of this approach for pain and anxiety 
control, and this technique became known as the Loma Linda technique (Dionne 
et al.,  2001). 
 
During the mid-1950s many different techniques were used to produce varying 
states of central nervous system depression, from conscious sedation to light 
general anaesthesia. 
 
Davidau  (Gelfman and Driscoll, 1977) first used diazepam (Valium) in 1965 as a 
sedative agent in dentistry.  O’Neil and Verrill (1969) used diazepam as the sole 
sedative agent for patients undergoing oral surgical procedures.  The Verrill sign, 
is today well-known and used as an indicator of the level of sedation. 
 
During the mid 1960s the ultra–light anaesthetic technique of Drummond-Jackson 
and the Jorgensen’s technique spread rapidly throughout many parts of the world 
as a way to make patients comfortable during surgical procedures. 
 
In 1965 Foreman (Dionne & Phero, 1991) offered a modification of the 
Drummond Jackson’s technique.  He used methohexital, an intravenous 
anaesthetic agent, to achieve sedation by using small doses of the drug.  Patients 
were maintained at a level where verbal contact was possible with the patient.  
The margin between sedation and anaesthesia was so close that adverse events 
were inevitable.  The practice of intermittent methohexitone for sedation was 
largely discontinued in the early 1970s.  Accidental anaesthesia did occur with 
intermittent methohexitone.  Intravenous sedative and anaesthetic drugs in current 
use have narrow margins of safety and therefore require professionals who are 
trained to administer them.  (Yagiela, 2001). 
 
In 1981, the first report on sedation in the UK was under the chairmanship of Dr 
John Wylie (Wylie Report, 1981).  A definition for conscious sedation was 
suggested which is still in use today.  Conscious sedation was defined as: 
“A technique in which the use of a drug or drugs produces a state of 
depression of the central nervous system enabling treatment to be carried 
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out, but during which verbal contact is maintained with the patient at all 
times.  The margin of safety of the drugs must be wide enough to render 
the unintended loss of consciousness unlikely”. 
Poswillo in his report (cited in Hawgood,  2014) suggested the following 
definition for conscious sedation: 
“A carefully controlled technique in which a single intravenous drug, or 
a combination of oxygen and nitrous oxide, is used to reinforce hypnotic 
suggestion and reassurance in a way which allows dental treatment to be 
performed with minimal physiological and psychological stress, but 
which allows verbal contact with the patient to be maintained at all times.  
The technique must carry a margin of safety wide enough to render the 
unintended loss of consciousness unlikely.  Any technique of sedation 
other than as defined above should be regarded as coming within the 
meaning of dental general anaesthesia.” 
 
The General Dental Council (England) (2005) still today endorse the need for 
conscious sedation for dental procedures as a safe alternative to general 
anaesthesia. 
 
3.2 Safety of Sedation 
 
3.2.1 Introduction 
 
Ambulatory anaesthesia, also known as outpatient or day–case anaesthesia, refers 
to the delivery of anaesthetic care where the patient is discharged home on the day 
of treatment.  Patient assessment, monitoring, drugs with wide safety margins, and 
recovery care remain important components of safe conscious sedation.  Our main 
objective with conscious sedation remains guarding the safety and well-being of 
our patients. 
 
To relieve anxiety, apprehension and distress in order to improve the patients’s 
coping resources, thereby enabling treatment to be carried out also remains a goal. 
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The question remains how can we make sedation safe for the patient? 
 
3.2.2 Procedural Sedation and Analgesia (PSA) Guidelines 
 
3.2.2.1 Introduction 
 
The practice of sedation showed a lot of progress over the past 20 years.  The 
development of sedation guidelines and training in sedation played a significant 
role in ensuring the safety of patients.  Sedation practitioners also realized the 
importance of monitoring of patients.  The question still is how many sedation 
practitioners follow sedation guidelines? 
 
The need for sedation guidelines arose in 1990 after a report of Poswillo (cited in 
Hawgood,  2014)  of severe adverse reactions related to administration of a 
sedative agent (a brand of alphaprodine).  The pharmaceutical company recalled 
the drug and stopped production. It seemed that misuse of drugs by practitioners, 
who were not well trained was the big reason for concern.   
 
After years of intense research and discussions the original “Guidelines for the 
Elective use of Conscious Sedation, Deep Sedation and General Anesthesia in 
Pediatrics” were published in 1986 (Creedon, 1986).  These guidelines were 
originally developed for use in the dental office and made a big contribution to 
sedation safety. 
 
Despite the publication of a number of guidelines on pain and anxiety control for 
dentistry it has become evident that there remain areas of confusion and lack of 
consensus (Department of Health, 2003).  Different opinions regarding 
definitions, doses, techniques of administration and suitable drugs, lead to the 
development of minimum requirements regarding the expected level of care 
required to promote the safety, and welfare of each patient. 
 
The General Dental Council (GDC) states in Maintaining Standards (Lowry, 
2000; Department of Health, 2003) in a guidance to dentists on professional and 
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personal conduct, “Dentists have a duty to provide and patients have a right to 
expect adequate and appropriate pain and anxiety control” A very effective way 
of providing pain and anxiety control is by the use of conscious sedation.  But 
they highlight that training of sedation practitioners must be part of this approach. 
 
As new information on monitoring and research are disclosed, and the use for 
conscious sedation for a variety of different procedures increase, so will the 
guidelines and safety aspects and recommendations be updated, to fulfill the 
broadening expectations of physicians and patients. 
 
On the issue of guidelines the American Academy of Pediatrics said, “Guidelines 
are systematically developed recommendations to assist practitioner and patient 
decisions about appropriate healthcare for specific clinical circumstances” 
(American Academy of Pediatrics. Committee on Drugs. 1992; Coté, 1994; 
Wilson, 1996; American Academy of Pediatrics et al., 2006).  These 
recommendations may be adapted, modified or rejected according to clinical 
needs and constraints.  Guidelines are not intended as standards or absolute 
requirements and their use cannot guarantee any specific outcome.  The guidelines 
establish a format for focusing attention to details, which should act to protect and 
promote the welfare of the patient who requires sedation.  This will lead to a 
decrease in adverse events (American Academy of Pediatrics. Committee on 
Drugs.  1992; Coté, 1994; Wilson, 1996; American Academy of Pediatrics et al., 
2006).  Guidelines are therefore not a recipe of a sedation technique but a 
guidance to patient safety. 
 
Paediatric sedation is an area of concern regarding safety, therefore sedation 
guidelines for children and adults.  Because children are sedated in a variety of 
settings, outside the hospital environment, by individuals with varying degrees of 
expertise, the above guidelines were re-evaluated and rewritten in 2002 to serve as 
a guidance to safety of children under sedation (American Academy of Pediatrics. 
Committee on Drugs.  1992; Coté, 1994; Wilson, 1996; American Academy of 
Pediatrics et al., 2006).  This was a huge step forward in ensuring quality control 
in sedation practice.   
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It was recognized that there has been considerable variation in the level of care 
provided to patients under sedation.  This was influenced by the facility used for 
the procedures, availability of monitoring equipment, levels of sedation and 
expertise of the sedation practitioner.  It was then decided that the standard of care 
for all sedated patients should be uniform.  Furthermore, the same standards were 
applied for both deep sedation and general anaesthesia, emphasizing that with 
deep sedation there was always the potential for loss of protective reflexes, 
unconsciousness and possible complications.  It may be unsafe for the patient. 
 
The major emphasis of all guidelines remain training and monitoring - this is 
supported by all professional societies involved in sedation practice and a crucial 
part of quality control.  The pulse oximeter, is now considered a valuable and 
possibly mandatory monitor to be used continuously with all levels of sedation, 
with the possible exception of anxiolysis, and specifically nitrous oxide sedation 
(American Academy of Pediatrics. Committee on Drugs. 1992; Coté, 1994; 
Wilson, 1996; American Academy of Pediatrics et al., 2006). 
“The development and implementation of guidelines probably elicits more 
controversy and emotional discomfort than any other activity professional 
organizations undertake.  Sedation guidelines, both among and within 
professional organizations, are a prime example.  Yet, guidelines offer a 
sense of accountability, direction, and integrity that would seem both 
demanded and appreciated by most elements of society” (Wilson, 1996). 
 
Any professional guideline on sedation should make a clear distinction on the 
roles of the operator-sedationist, and the independent sedationist, dedicated to 
providing and supervising only the sedation.  This is all about the safety of the 
patient.  In both instances specific training in all aspects of safe sedation practice 
should be mandatory, especially supervised clinical training. 
 
Where any other level of sedation other than anxiolysis is required, it is strongly 
recommended that the same medical practitioner does not act as both operator and 
sedationist.  It is however acknowledged that there is a role for the trained 
operator-sedationist in sedation practice.  When a multiple-drug technique is 
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practiced, it is advisable that an independent sedationist and an observer be 
involved in the sedation process, as in this research study. 
 
The value of training is not only highlighted in sedation guidelines.  Professional 
organizations also support it.  The GDC states, “dentists have a duty of care - to 
administer conscious sedation only within the limits of their knowledge, training, 
skills and experience” and that dentists should “have completed relevant 
postgraduate education and training”, and “have clinical experience of the 
particular conscious sedation technique employed”.  The guidelines in the 
document are applicable to both dental and medical practitioners who are 
practicing conscious sedation in all clinical settings: 
“Where a second dental or medical practitioner is providing conscious 
sedation for a patient, the treating dentist must ensure that the person 
acting as the sedationist has undertaken relevant postgraduate training, 
accepts the definition of conscious sedation and the principle of minimum 
intervention and has specific experience of the use of conscious sedation in 
dentistry ---“(General Dental Council, 2005). 
 
This is a very important statement by the GDC on the importance of training for 
practitioners involved in sedation practice and should be supported.  This is about 
patient safety. 
 
The UK Academy of Medical Royal Colleges and their Faculties (Royal College 
of Anaesthetists, 2001), under the chairmanship of the Royal College of 
Anaesthetists, wrote in, “Implementing and ensuring Safe Sedation Practice for 
healthcare procedures in adults” “The key point is that safety will be optimized 
only if practitioners use defined methods of sedation for which they have received 
formal training”.   
 
The Standing Dental Advisory Committee in the UK has it right when they say, 
“the key to safe practice is the high level of competence based on a solid 
foundation of theoretical and practical supervised training, progressive updating 
of skills and continuing experience” (Department of Health,  2003). 
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For safety patient sedation practitioners must understand what the sedation 
continuum means; it is all about the level of consciousness (Appendix 1). The 
deeper the patient becomes, the higher the possibility of adverse events. 
 
Table 1. The continuum of sedation and sedation end points (SASA, 2015) 
 Minimal 
sedation/ 
anxiolysis 
Moderate 
sedation/ 
analgesia 
“conscious 
sedation” 
Deep 
sedation 
/analgesia 
General 
anaesthesia 
Responsiveness Responds to 
verbal stimuli 
Purposeful 
response to 
verbal or 
tactile stimuli 
Purposeful 
response only 
after repeated 
or painful 
stimuli 
Unable to 
rouse 
Airway Unaffected No 
intervention 
required 
Intervention 
may be 
required 
Intervention 
often 
required 
Spontaneous 
ventilation 
Unaffected Adequate May be 
inadequate 
Frequently 
inadequate 
Cardiovascular 
function 
Unaffected Usually 
maintained 
Usually 
maintained 
May be 
impaired 
 
In South Africa we have Guidelines for Procedural Sedation and Analgesia for 
both adults and children. They serve as a guide for safe sedation practice and are 
also acknowledged at international level. 
 
The following is a very important statement in the guidelines,“all health care 
professionals participating in the assessment, administration, monitoring and 
recovery of patients requiring sedation are accountable for safe practice. The 
patient is entitled to the same standard of care, whether the procedure is 
undertaken in a physician’s office, a remote facility, or in an operating theatre. 
These guidelines are for use by all medical practitioners and their teams, in order 
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to provide safe sedation, analgesia and anxiolysis for adult patients and children” 
(SASA, 2010, SASA, 2015).   
 
SASA guidelines emphasise the role to provide a reference that will enable all 
practitioners to act within a framework to ensure patient safety and the successful 
performance of procedures and include the following (SASA, 2010, SASA, 
2015):  
 Patient selection and assessment 
 Informed consent 
 Environmental and clinical setting 
 Personnel 
 Fasting guidelines 
 Standards of monitoring 
 Education and training 
 Recovery and discharge 
 Documentation required during PSA  
 Behaviour management 
 
The sedation of children is different from the sedation of adults, therefore we have 
specific guidelines for children.  Children differ anatomically and physiologically 
from adults, therefore it is necessary to highlight some safety aspects.  A child’s 
ability to control his or her own behaviour to cooperate for a procedure depends 
both on chronologic and developmental age (American Academy of Pediatrics. 
Committee on Drugs. 1992; Coté, 1994; Wilson, 1996; American Academy of 
Pediatrics et al., 2006).  Studies have shown that it is common for children to pass 
from the intended level of sedation to a deeper, unintended level of sedation 
(American Academy of Pediatrics. Committee on Drugs. 1992; Coté, 1994; 
Wilson, 1996; American Academy of Pediatrics et al., 2006).  Therefore children 
must be closely monitored. 
 
The goals of paediatric sedation in the paediatric patient for diagnostic and 
therapeutic procedures are to  
 guard the patients’s safety and welfare; 
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 minimize physical discomfort and pain;   
 control anxiety, minimize  psychological trauma, and maximize the 
potential for amnesia;  
 control behaviour and/or movement to allow the safe completion of the 
procedure;  
 return the patient to a state in which safe discharge from medical 
supervision is possible (American Academy of Pediatrics. Committee on 
Drugs. 1992; Coté, 1994; Wilson, 1996; American Academy of Pediatrics et 
al., 2006).  Although written in 2006 we still accept those goals important 
for safe paediatric sedation. 
 
Looking at all the guidelines mentioned it is clear that the safety and well-being of 
the patient must take precedence over all other consideration.  The main factors 
governing safety are the knowledge and skill of the sedation practitioner, who 
should therefore take his/her responsibilities in this regard very seriously.  The 
drugs and techniques used for conscious sedation should have a margin of safety 
sufficient to render unintended loss of consciousness or loss of protective reflexes 
unlikely.  All necessary equipment and drugs (Appendix 2) to protect the patient 
from the effects of unintended oversedation, to rapidly reverse such oversedation, 
or to deal with emergencies must be immediately available (Ad Hoc Committee of 
SADA, 2001). 
“The safe sedation of children requires a protective net composed of 
skilled personnel, vigilance, monitoring equipment, common sense in 
selecting patients suitable for sedation, appropriate selection of drugs 
and drug dosage, age and size appropriate airway management 
equipment, and drugs to sustain life. Seizures, respiratory arrests, and 
deaths in a variety of practice settings have occurred when any one of 
these was deficient.” (American Academy of Pediatrics. Committee on 
Drugs. 1992; Coté, 1994; Wilson, 1996; American Academy of 
Pediatrics et al., 2006). 
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Part of the safety net of sedation is to have a sedation plan.  A commonly used 
acronym that is useful in planning and preparation for a sedation procedure is 
SOAPME (American Academy of Pediatrics.  Committee on Drugs, (1992):   
 
S (suction) –  size-appropriate suction catheters and a functioning suction 
apparatus 
O (oxygen) –  adequate oxygen supply and functioning flow meters/other 
devices to allow its delivery 
A (airway) –  size-appropriate airway equipment 
P (pharmacy) – all the drugs needed as well as antagonists  
M (monitors) – as stipulated in SASA sedation guidelines 
E (equipment) – emergency equipment for example, defibrillator (American 
Academy of Pediatrics.  Committee on Drugs.  1992; Coté, 
1994; Wilson, 1996; American Academy of Pediatrics et al., 
2006). 
 
3.2.2.2 Patient Selection and Assessment 
 
Careful pre-operative assessment will ensure that correct decisions are made 
regarding suitability of a patient for conscious sedation for the proposed operative 
procedure (Ad Hoc Committee of SADA, 2001).  Patients should be assessed in 
accordance with the American Society of Anesthesiologists (ASA) Physical 
Status Classification System (Table 2).  
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Table 2. (ASA) Physical Status Classification System. (SASA, 
2015) 
 
Class I A normally healthy patient 
Class II A patient with mild systemic disease 
Class III A patient with severe systemic disease that limits activity, but is 
not incapacitating 
Class IV A patient with severe systemic disease that is a constant threat to 
life 
Class V A moribund patient not expected to survive 24 hours with or 
without an operation 
“E” An emergency procedure is denoted by the letter E following the 
class number 
 
All sedation guidelines recommend that only ASA I and II patients be considered 
for sedation outside the operating room.  (Coté, 1994; Wilson, 1996; Scottish 
Intercollegiate Guidelines Network, 2002;  Hallonsten et al.,  2003;  American 
Academy of  Pediatrics; American Academy of Pediatric Dentistry, 2004;  
American College of Radiology, 2005; American Academy of Pediatrics et al., 
2006 and SASA guidelines, 2015). 
 
Although the ASA classification is not a risk classification, it is used worldwide.  
Patients assessed as ASA class III, IV or V require higher levels of monitoring 
and care and should be done in-hospital in a fully equipped operating theatre, with 
a full range of emergency drugs and resuscitation equipment available. 
 
No patient should be considered for sedation without a focused airway 
assessment. Various tools are available to assess the airway (SASA, 2015). 
 
The patient should fill in a medical history questionnaire designed to disclose any 
risk factors, or whether he/she is taking any drugs that may necessitate 
modification of technique or drug dosage, or the use of special equipment.  It may 
also be decided that the patient does not qualify for sedation outside the operating 
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theatre.  Ability to communicate with the child is essential, and identification of 
those children unsuitable for sedation is crucial.  It is useful to record the pre-
sedation assessment on the pre-sedation medical history checklist.  An example of 
the medical history questionnaire is included in Appendix 3  (SASA, 2015).  It is 
useful to also record the pre-sedation assessment on the Sedation Monitoring 
Chart (Appendix 4). 
 
In order to look after safe sedation practice SASA guidelines recommend that no 
children under 5 years of age should be sedated by practitioners who do not have 
the necessary training, and extensive experience in paediatric sedation. 
 
Sedation of children below the age of 1 year is said to be contraindicated because 
of the possibility of unsafe practice, it is never really relevant in the dental setting.  
Certain children are at increased risk for complications and should be assessed by 
a specialist anaesthetist trained in sedation or a highly experienced trained 
sedation practitioner. 
 
3.2.2.3 Informed consent 
 
Written and verbal informed consent must be obtained and documented prior to 
the administration of drugs for sedation.  Informed consent must never be 
obtained after administration of sedative drugs.  The nature of the procedure to be 
performed may not be changed after the administration of a sedative drug.  
Informed consent should include an explanation of the procedure, the proposed 
sedation technique, other options available, and an explanation of the risks and 
benefits of appropriate alternatives.  Patients must be informed of the possibility 
that the sedation may fail and that the procedure may have to be abandoned or 
performed under general anaesthesia at a later date.  Consent must be obtained for 
both the procedure and the sedation (Appendix 5).  The patient must be given the 
opportunity to ask questions (SASA, 2015). 
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3.2.2.4 Environment and clinical setting 
 
Sedation in children should only be performed in an environment meeting all the 
criteria for safe practice for example, the facilities, personnel and equipment to 
manage paediatric emergency situations must be immediately available (Scottish 
Intercollegiate Guidelines Network, February 2002). 
 
A protocol for access to back-up emergency services shall be clearly identified 
with an outline of the procedures necessary for immediate use (Wilson, 1996 and 
American Academy of Pediatrics, et al., 2006). 
 
It is critical that a complete range of sizes of emergency and monitoring 
equipment be available.  The complete list of equipment could be found in 
Appendix 2.  
 
SADA guidelines say premises suitable for the safe practice of conscious sedation 
must have an oxygen supply, suction, an emergency electricity supply, a pulse-
oximeter, all necessary drugs, including emergency drugs, a chair or table which 
can be tilted to the Trendelenburg position, a fail-safe relative analgesia machine 
which cannot deliver a hypoxic gas mixture, and resuscitation equipment  (Ad 
Hoc Committee of SADA,  2001). 
 
3.2.2.5 Personnel 
 
The availability of trained personnel is crucial for safe sedation practice. They 
“are called” the team for sedation procedures and accepted by all international 
guidelines.  
 
The team should be, 
 An operator-sedationist where applicable for short procedures where the 
operator-sedationist is both the operator and sedation practitioner, and 
standard sedation techniques are used.  For procedures lasting less than 20 
minutes the operator’s assistant, can also be the observer.  If more than 20 
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minutes a separate observer is required, with airway certification, to help 
with monitoring and rescue when necessary 
 An observer as described above 
 When advanced sedation techniques are used a dedicated sedation 
practitioner must be present.  An observer is required to help with 
monitoring and rescue when necessary (SASA, 2015). 
 
Some sedation guidelines claim that there must be a minimum of three 
appropriately trained staff present: the operator, the practitioner administering 
sedation and monitoring the patient, and at least one additional staff member to 
provide assistance and rescue if necessary (American College of Radiology, 2005 
and Smith, 2009). 
 
The ability to rescue means that practitioners must be able to recognize the 
various levels of the sedation and have the skills necessary to rescue a patient 
from a deeper than intended level of sedation (Cote, 1994; Wilson, 1996 and 
American Academy of Pediatrics  et al., 2006). 
 
The team must demonstrate evidence of continuing education in sedation (Scottish 
Intercollegiate Guidelines Network, 2002). 
 
3.2.2.6 Fasting Guidelines 
 
Preoperative fasting is a very controversial issue. It is thought that fasting reduces 
the risk of aspiration.  
 
Fasting guidelines have been in a state of flux in recent years due to studies which 
indicate that small amounts of clear fluids taken 2 hours prior to surgery may in 
fact increase gastric emptying (Sandhar et al., 1989). 
 
Not all sedation practitioners agree on the need for fasting.  Dental societies in the 
UK feel that fasting is not normally required, however some authorities 
recommend the same fasting requirements as for general anaesthesia (Department 
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of Health, 2003).  Guidelines for fasting periods before elective sedation should 
generally follow those used for elective general anaesthesia (Scottish 
Intercollegiate Guidelines Network, 2002). 
 
When a simple sedation or standard technique for example, nitrous oxide sedation 
is planned, no fasting is necessary (SASA, 2015). 
 
Where advanced techniques (including dissociative and non-dissociative 
techniques) and/or deep sedation are planned, anaesthetic fasting guidelines 
should be used (SASA, 2015).  The patient is allowed to take before sedation, 
 Clear fluids    2 hours 
 Breast milk    4 hours 
 Formula feed and solid food  6 hours 
 
For the emergency patient, where proper fasting has not been assured, the 
increased risk of sedation must be weighted against the benefits of the treatment, 
and the lightest effective sedation should be used (Hallonsten et al.,  2003). 
 
3.2.2.7  Monitoring 
 
Monitoring in sedation means, 
 Clinical monitoring and 
 Electronic monitoring 
 
All patients undergoing intravenous sedation must be monitored continuously by 
clinical (Hallonsten et al., 2003), and electronic means. 
 
Pulse oximetry plays an important role in monitoring.  A pulse-oximeter is the 
minimum monitoring equipment for almost all sedation cases done under 
procedural sedation, with the possible exception of nitrous oxide sedation.  (Ad 
Hoc Committee of SADA, 2001;  American Academy of Pediatrics et al., 2006 
and SASA, 2015).  There must be regular monitoring and recording of pulse rate, 
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oxygen saturation and blood pressure.  This must be recorded on a sedation flow 
sheet. 
 
Depending on the clinical status of the patient for example, the obese patient, 
other monitors such as an ECG or capnography may be required (ANZCA, 2003; 
Smith, 2009; SASA, 2015).  Automated blood pressure apparatus are available; 
the oxygen saturation levels, pulse rate, and end-carbon dioxide levels can also be 
evaluated with the same apparatus. 
 
For simple sedation techniques, pulse oximetry and blood pressure measurements 
must be used. 
 
For advanced sedation techniques pulse oximetry, ECG and non-invasive blood 
pressure (NIBP) monitoring must be used, capnography is recommended, 
especially in situations where continuous airway monitoring is difficult.  A 
precordial stethoscope is a useful monitoring device. 
 
Pulse-, and respiration rates, blood pressure, and oxygen saturation levels must be 
taken at regular intervals during the procedure, usually at 10 minute intervals. 
Clinical monitoring includes (Hallonsten et al., 2003, SASA, 2015) response by 
the patient to mild physical stimulation and verbal command.  This indicates 
moderate sedation and analgesia, the level that we recommend for procedures 
outside the operating theatre.  Clinical monitoring also includes level of 
consciousness (L.O.C) (Appendix 1), colour of mucosae, breathing rate and 
pattern, and body language (signs of pain or anxiety). 
 
Monitoring of the airway, respiratory rate and pattern, heart rate, oxygen 
saturation levels and the patient’s LOC should continue in the recovery area 
(Appendix 1) until discharge criteria are met (Appendix 6). 
 
In order to avoid the potential complications of both excessive and inadequate 
sedation, it is necessary to regularly assess and document the level of conscious 
sedation (LOC) using a sedation assessment scale.  Various sedation scales are 
available.  The COMFORT scale is a subjective physiological and behavioural 
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scoring system.  Eight variables – mean arterial blood pressure, heart rate, muscle 
tone, facial tension, alertness, calmness/agitation, respiratory behaviour and 
physical movement – are scored after 2 min period of observation (Smith, 2009). 
 
Newer scales like the Wilson sedation scale and University of Michigan sedation 
scale (UMSS) (SASA, 2015)  are available and more practical than older scales 
Sedation practitioners choose a sedation that they are familiar with. 
 
3.2.2.8 Education and Training 
 
Sedation practice is in an evolution and revolution.  Education and training of all 
sedation practitioners are supported by all international guidelines and sedation 
societies.  Only in this way we can be certain that sedation can be done safely 
(SASA, 2015). 
 
Both theoretical and practical training are necessary.  Supervised clinical training 
in sedation techniques are mandatory to ensure safe practice. 
 
A sound knowledge of the pharmacology of drugs is essential for any intending 
sedation practitioner.  
 
Education and training in the theory, methods and techniques of sedation can be 
provided in academic institutions where sedation is practised and taught; or in 
formal short or more extended courses regularly offered.   
 
Knowledge and skills must be updated regularly (SASA, 2015). 
 
3.2.2.9 Recovery and discharge criteria 
 
The ideal is that patients must recover in an appropriate and suitably equipped 
recovery room, with a health care professional trained in basic life support 
monitoring him or her.  It is also accepted that patients recover in the procedure 
room.  All the necessary monitoring equipment as mentioned previously must be 
 
 
 
 
30 
 
available to monitor the patient.  The sedation practitioner must assume overall 
responsibility for patients in the recovery area and may not leave the premises 
until discharge criteria are met. Recovery from sedation is a progressive step-
down from completion of treatment through to discharge.  A member of the dental 
team for example, nursing sister must supervise and monitor the patient 
throughout this period until discharge criteria are met (Department of Health, 
2003). To decide whether a patient can be discharged home the sedation 
practitioner can use a validated tool such as the modified Aldrete scoring system 
(Table 3), or the Modified Post Anesthesic Discharge Scoring System (MPADSS) 
(Table 4) (SASA, 2015). 
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Table 3. Modified Aldrete scoring system (SASA, 2015) 
Modified Aldrete scoring system Score 
Level of consciousness 
Fully awake 
Arousable on calling 
No response 
 
2 
1 
0 
Oxygen saturation (%) 
> 90% breathing room air 
Oxygen required to maintain saturation > 90% 
< 90% even when breathing oxygen 
 
2 
1 
0 
Circulation/blood pressure 
Systolic BP within 20 mmHg of presedation level 
Systolic BP within 20-50 mmHg of presedation level 
Systolic BP > 50 mmHg of presedation level 
 
2 
1 
0 
Movement/activity 
Able to move all extremities on command  
2 extremities 
Doesn’t move extremities 
 
2 
1 
0 
Respiration 
Able to breathe and cough freely  
Dyspnoea, shallow or limited breathing  
Apnoea 
 
2 
1 
0 
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Table 4. Modified Post Anaesthetic Discharge Scoring System 
(SASA, 2015) 
Modified Post Anesthetic Discharge Scoring System (MPADSS) Score 
Vital Signs 
The vital signs must be stable and consistent with age and 
preoperative baseline 
BP and pulse within 20% of preoperative baseline 
BP and pulse within 20-40% of preoperative baseline 
BP and pulse > 40% of preoperative baseline 
 
 
 
2 
1 
0 
Activity level 
The patient must be able to ambulate at preoperative level 
Steady gait, no dizziness, or meets preoperative level 
Requires assistance 
Unable to ambulate 
 
 
2 
1 
0 
Nausea and vomiting 
The patient should have minimal nausea and vomiting before 
discharge  
Minimal: successfully treated with oral medication 
Moderate: successfully treated with intramuscular medication 
Severe: continues after repeated treatment 
 
 
 
2 
1 
0 
Pain 
The patient should have minimal or no pain before discharge 
The level of pain should be acceptable to the patient 
The pain should be controlled by oral analgesics 
The location, type and intensity of the pain should be consistent 
with anticipated postoperative discomfort 
Acceptability: 
Yes 
No 
 
 
 
 
 
 
2 
1 
Surgical bleeding 
Postoperative bleeding should be consistent with expected blood 
loss from the patient 
Minimal: does not require dressing changes 
Moderate: up to two dressing changes required 
Severe: more than three dressing changes required 
 
 
 
2 
1 
0 
 
Although the Aldrete score was not originally designed for use in ambulatory 
patients after sedation, it is today commonly used to determine when patients are 
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ready for discharge home.  The MPADSS was designed to determine whether 
patients can go home after ambulatory surgery, and not specifically for assessing 
patients undergoing PSA.  Vital signs (blood pressure, heart rate, respiratory rate, 
oxygen saturation level, level of consciousness, temperature, and pain levels) 
must be measured and documented at regular intervals (Appendix 6). 
 
Although still widely used, the modified Aldrete scoring system has been largely 
superseded by the MPADSS as a tool to determine home readiness (Table 4). 
When using the MPADSS, patients are judged as fit for discharge when the score 
is ≥ 9 out of a maximum of 10.  It is no longer necessary to ensure that the patient 
is able to take in fluids orally, or that he or she has passed urine prior to discharge 
home. 
 
A responsible adult must accompany the patient home.  Written and verbal 
instructions, including the contact details of a physician in the event of 
complications, must be given to both the patient and the carer.  The physician 
must be satisfied that aftercare is optimal before the patient is discharged.  
Following the procedure, the patient is not permitted to do any of the following 
for 24 hours (SASA, 2015): 
 Drive a motor vehicle. 
 Operate machinery. 
 Drink alcohol. 
 Sign any legal documents. 
 
Carers are advised to seek immediate help in case of vomiting, strange and 
unusual behaviour, or any other symptom or sign that does not seem normal for 
the patient. Carers should also be instructed to look for any breathing difficulties.  
Medication must be administered as prescribed by the physician.  The intake of 
food or fluids must be introduced slowly.  The patient must stay at home and rest 
quietly. 
 
Patients residing in rural areas must spend the first 24 hours post procedure within  
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a reasonable distance of medical assistance, or must guarantee that they have 
access to a telephone or medical care in case of complications. 
The Discharge Scoring System (Table 5, Appendix 6) is recommended to 
establish readiness for discharge from the recovery area to the ward in-hospital.  
The child should score 12 prior to discharge.  In addition there should be no 
procedural or surgical complication e.g. bleeding.  
 
Table 5. Discharge Scoring System (SASA, 2015) 
PHYSICAL 
SIGN 
CLINICAL LEVEL SCORE 
Level of 
consciousness 
Fully awake/alert/answer questions 2 
 Rousable to verbal command 1 
 No response 0 
Respiration Able to take deep breaths and cough adequately 2 
 Shallow breathing with poor cough 1 
 Apnoeic periods 0 
Oxygen 
saturation 
>96% on room air 2 
 Requires oxygen to maintain saturations >90% 1 
 Saturation <90% with oxygen 0 
Movement Able to move all 4 extremities on command 2 
 Able to move 2 extremities on command 1 
 Not able to move extremities on command 0 
Temperature 36 – 38° C 2 
 35.5 – 35.9° C or 38.1 – 38.5° C 1 
 <35.5° C or > 38.5° C 0 
Pain Minimal discomfort or pain 2 
 Significant pain 0 
 
A discharge questionnaire (Appendix 6) can aid in determining if the patient is 
ready for discharge home.  All patients receiving sedation shall be monitored until 
appropriate discharge criteria are satisfied. 
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3.2.2.10 Documentation during Procedural Sedation and 
Analgesia 
 
All the necessary documents are available in the guidelines of SASA for 
Procedural Sedation and Analgesia (SASA, 2015). 
 
Documentation for sedation must include details of: 
 Documentation before sedation  
o Medical questionnaire (Appendix 3). 
o Informed Consent: the patient record must document that appropriate 
informed consent was obtained according to local, state and institutional 
requirements (American Academy of Pediatrics et al.,  2006)  (Appendix 
5). 
o Basic equipment and drugs for procedural sedation and analgesia 
(Appendix 2) 
o Pre- and post sedation instructions (Appendix 7) 
 Documentation immediately before the sedation process  
o Pre-procedure checklist (Appendix 8) 
 Documentation during sedation  
o Sedation monitoring chart, including practical clinical monitoring  
(Appendix 4) 
o Sedation scoring system (Appendix 1) 
 Documentation after sedation  
o Post-operative record and discharge criteria questionnaire (Appendix 6). 
 
It is good to remember that if we have not written down what we did, it never 
happened!  (Hallonsten et al., 2003). 
Pre- and post operative instructions in writing must be given preferably in 
advance of the procedure to the child and the parent or guardian (Appendix 7). 
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3.2.2.11 Psychological preparation of children for Procedural 
Sedation and Analgesia 
 
Preparing children and their families for procedures and medical events can 
significantly increase their confidence and their ability to cope with health care 
experiences.  Preparation should include all sensory information, a description of 
the sequence of events, and the expected duration of the procedure.  When 
preparing the child, let him/her smell, feel, and touch the items that may be used 
for example, smell the alcohol preptic swab, touch the wetness of the swab, and 
feel how cool it is to the touch (SASA, 2010). 
 
Talking to children is different from talking to adults.  In order to provide helpful 
information, the child’s developmental level, age, culture, and education should 
be taken into consideration.  Young children have no sense of reason; “you will 
feel better after this medicine has been given” is of no apparent benefit to them.  
They remain fearful. 
 
Medical terminology should be avoided, and further explanation to both child and 
parents is usually necessary.  The use of pictures or actual equipment is strongly 
recommended.  
 
Communication with the children and parents is extremely important.  This is 
especially the case when the child is expected to undergo on-going or repeated 
treatment.  Looking down, or talking over a child, should be avoided.  Children 
are much more receptive to information when one is at their level.  
 
The caregiver of each child plays a vital role in the hospitalisation of young 
children.  They have an understanding of the child’s needs, and are best equipped 
to interpret the child’s behaviors and reactions to, and in, the hospital 
environment.  Frequent conversations with caregivers are crucial to success, and 
sufficient time should be made available for asking and answering questions.  
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By providing accurate and developmentally appropriate information, a family’s 
level of uncertainty can be reduced, and their sense of control and involvement 
increased.  This can lead to less emotional distress, and result in the continuation 
of accurate information processing and the development of positive coping 
strategies.  This behavioural management strategy is important for patients.  
 
3.2.3 Drugs for PSA 
 
Drugs and dosages for PSA in children and adults are available in Appendix 9. 
 
3.2.3.1 Introduction 
 
Practitioners should have an in-depth knowledge of the pharmacology of the 
drugs they intend to use and their potential complications.  Knowledge of each 
drug’s time of onset, peak response, and duration of action is essential (American 
Academy of Pediatrics et al., 2006; SASA, 2015). 
 
Intravenous anaesthetic agents must only be used by an appropriately trained 
medical or dental practitioner, and titrated to response.  Continuous monitoring of 
the LOC is mandatory.  
 
Drugs for sedation should have the following general characteristics: 
 large margin of safety, 
 painless route of administration,  
 rapid onset and rapid recovery,  
 easy reversibility,  
 no side-effects.  
 
Unfortunately no drug or combination of drugs meets the requirements of an ideal 
drug. 
 
Drugs used for PSA can be synergistic when used in combination and it is 
mandatory that the doses be reduced accordingly, and titrated to effect in divided 
doses.  The sum of the incremental doses must not exceed the recommended 
maximum dose.  In general, the drugs selected for PSA should have duration of 
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action in keeping with the duration of the procedure.  Sufficient time for peak 
brain effect (the target site) must be allowed, to prevent accumulation of 
sedatives. 
 
SASA (2015) recommend that general anaesthetic induction agents (propofol, 
ketamine, etomidate) and the short-acting opioids (fentanyl, alfentanil, sufentanil) 
only be used by those formally trained in anaesthesia, or by experienced sedation 
practitioners with anaesthetic experience who are trained in specific sedation 
techniques.  Sedation practitioners using these drugs must have at least a 
qualification in ALS/APLS. 
 
Thus, the choice to use IV sedation in clinical practice requires, 
 judicious selection of drugs,  
 administration at the recommended rate,  
 limiting the dose to the maximum recommended by the manufacturer,  
 only employing drug combinations when greater efficacy can be 
demonstrated in comparison to a full therapeutic dose of a single agent, and  
 decreasing the dose of the individual agents when a combination is used 
(Giovannitti and Trapp, 1991).   
 
3.2.3.2 Drugs used for Procedural Sedation and Analgesia 
 
Drugs are comprehensively covered in the SASA Guidelines on PSA (SASA, 
2015).  The following is a basic summary of drugs used in the study (see 
Appendix 9). 
 
 Midazolam 
 
Midazolam is the most commonly used benzodiazepine (BZD) for sedation. 
(SASA, 2015).  
 
It is a short-acting benzodiazepine with sedative, anxiolytic, amnestic, 
anticonvulsant, and muscle relaxant effects.  It has no analgesic effect but is 
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the most commonly used sedative in sedation practice. The drug can cause 
respiratory depression and must be titrated to effect.  It must be used with 
care in elderly patients.  
 
Paradoxical reactions for example agitation occur in up to 15% of patients.  
This can be especially in uncomfortable in children. 
 
The high lipid solubility of midazolam produces a rapid onset, a more 
profound sedation and better amnesia according to some clinicians (Ochs et 
al., 1986). 
 
The clinical effects after intravenous administration is usually seen after 2-
3 min (Nordt and Clark, 1997).   It usually “gets to the brain” in 10-12 min. 
 
Sedatives like midazolam do not produce analgesia and must not be used 
alone for painful procedures.  If sedatives are used, analgesics are usually 
administered first. 
 
Midazolam is used extensively as a primary agent, sometimes together with 
opioids, for intravenous sedation.  Caution must be exercised when 
combining benzodiazepines, or other sedatives, with opioids as the drugs 
work synergistically. 
 
Although benzodiazepines used for intravenous sedation are seen as safe 
agents it must be remembered that their clinical effects are highly variable.  
They must be carefully titrated to clinical effect rather than administered as 
a bolus injection.  When midazolam is slowly titrated intravenously to a 
clinical endpoint, no clinically significant ventilatory changes occur 
(Giovannitti, 1987). 
 
The distribution half-life for midazolam is 6-15 min.  The short duration of 
action of midazolam is attributed to its very high rate of metabolic clearance 
and rapid rate of elimination.  The elimination half-life for midazolam is 1-4 
hours, which is faster than that of other benzodiazepines.  This makes it an 
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attractive option to use for sedation outside the hospital setting.  In addition, 
the metabolites of midazolam are mostly inactive (Arendt, Greenblatt and 
De Jong, 1983).  
 
The elimination half-life for midazolam is prolonged in the elderly patient.  
The dose requirements is lower in the elderly patient. 
 
 Propofol 
 
Is a non-opioid, non-barbiturate, sedative/hypnotic intravenous anaesthetic 
agent used for general anaesthesia and procedural sedation? 
What make this drug so attractive for PSA is the rapid onset and short 
duration of action (half life of 4.4 minutes in adults, children 9 minutes) due 
to rapid equilibration between the blood and the brain.  There is quick 
redistribution of the drug to peripheral tissues and a rapid metabolic 
clearance from the blood.  It is unfortunately not an analgesic drug. 
Propofol is associated with a dose-dependent risk of respiratory depression.  
This risk is heightened with concomitant opioid use, can be problematic for 
the clinician wishing to provide analgesia with opioids, as propofol has no 
intrinsic analgesic properties.  It is claimed that when we combine ketamine 
and propofol (ketofol) we need less propofol and then a lower incidence of 
respiratory-related adverse events. 
 
Because of the few side effects and smooth recovery characteristics, 
propofol has proven to be quite useful in paediatrics (Hansen et al., 1997), 
geriatric, (Chan et al., 1996; Ganapthy et al., 1997) and mentally and/or 
physically handicapped patients (Roelofse and Van der Bijl, 1994).   
 
Propofol can be used for PSA in children and adults, as boluses and/or 
continuous infusion (SASA 2010 and 2015). 
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 Ketamine 
This drug has withstood the test of time.  Ketamine is not the ideal drug for 
single drug administration because of the side effect profile for example,   
nausea and vomiting,  but can be combined with other drugs for example,  
propofol.  It may not be so popular for general anaesthesia anymore but the 
drug still occupies a unique position in the armamentarium of the sedation 
practitioner. 
Ketamine is one of the most significant drugs available for PSA and we 
discover more are more about this drug.  A problem with significant drugs is 
that you may find people that may use it for other purposes; one of our 
biggest problems at the moment centers around the recreational use of the 
drug.  The drug is classified as a N-methyl –D-aspartate glutamate receptor 
antagonist (NMDA). 
Ketamine dissociates the thalamo-neocortical and limbic systems (emotional 
brain). The CNS is in effect dissociated from outside stimuli for example, 
pain, sight, sound (unpleasant experiences). 
The dissociative state is characterized by, 
 sedation 
 intense analgesia 
 amnesia 
 intact protective reflexes for example, coughing and swallowing and 
stabile cardiovascular and respiratory systems.  All the characteristics 
that we want when using ketamine for procedural sedation. 
Ketamine, a dissociative drug, is a remarkably versatile compound.  It can 
be administered orally, rectally, intranasally, intravenously, or 
intramuscularly (SASA, 2015).  Ketamine is pharmacologically reasonably 
predictable: its onset is within 1-2 min after intravenous use, and 5 min after 
intramuscular administration, and duration of action is about 45 min. 
Parenteral ketamine can be used for sedation as boluses, in an infusion, or 
combined with other drugs for example, propofol.  
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The analgesic properties of ketamine are evaluated.  A number of 
suggestions for ketamine pain therapy in the perioperative period and for 
patients with chronic pain are being evaluated (Himmelseher and Durieux, 
2005).  
Ketamine is used extensively for paediatric procedures in and outside of the 
operating room (SASA, 2015).  It is often combined with propofol for PSA. 
The reasons for the popularity of ketamine are clear: it provides effective 
analgesia and sedation with a low incidence of complications, such as the 
cardiorespiratory depression that can be seen after use of benzodiazepines or 
narcotics.  
 
As with the use of all sedative drugs side effects do occur.  It is possible to 
see nausea and vomiting, hallucinations, and dissociation.  This however 
dose dependent, and less often seen in the doses that we use for PSA. 
 
 Fentanyl 
 
Opioids such as fentanyl are used for analgesia and sedation, although 
sedation is a secondary effect (Smith, 2009).  Fentanyl is an extremely 
potent analgesic which is 80100 times as potent as morphine.  It is 
especially popular to use in children for various procedures (Jaffe and 
Martin, 1985). 
 
Fentanyl is an analgesic agent and produces little if any euphoria or mood 
alteration. Fentanyl has been associated with respiratory depression, chest-
wall rigidity, or stiff-chest syndrome.  The drug should also be used with 
caution in patients with restrictive or obstructive pulmonary diseases.  
Caution should be used with asthmatic patients as well.  
 
Practitioners administering fentanyl intravenously should be experienced 
sedation practitioners with airway management skills.  The drug should be 
titrated to effect when used for sedation. 
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Fentanyl should not be used as the sole analgesic agent for PSA, but rather 
to augment the effects of other analgesics.  When used in combination with 
other respiratory depressant drugs (such as midazolam), doses should be 
decreased and titrated to effect.  Extreme care should be exercised in the 
postprocedural period, when the stimulus of the procedure has passed but 
the drug is still active and more likely to cause respiratory depression 
(SASA, 2015). 
 
Tables 6 and 7 show the pharmacokinetic and pharmacodynamic parameters 
of the drugs used in the research study.  
 
Table 6. Pharmacokinetic parameters of drugs used (Colson, 2005). 
Drug 
pKa 
Partition 
Coefficient 
Elimination 
Half-Life 
(hours) 
Volume of 
distribution 
(Liters/kg) 
Context- 
Sensitive Half-
Life (minutes)  
Midazolam 6.15  1-4 1-1.5 180 
Propofol 11.0 5012 0.5-1.5 1.8-5.3 55 
Ketamine  7.5  2-3 2.5-3.5  
Fentanyl  8.4 955 3.1-6.6 3-5 260 
 
Table 7. Pharmacodynamics of drugs used (Colson, 2005). 
Drug Anxiolysis* Sedation Hypnosis Analgesia Amnesia Anesthesia Dependency 
Midazolam + + + 0 + + + 
Propofol 0 + + 0 +  + 
Ketamine 0 0 0 + + +/D 0 
Fentanyl 0 + + + 0 + + 
 
3.2.3.3 Drug interactions 
 
As sedation practitioners we often use combinations of drugs.  We must therefore 
be aware of possible drug interactions between the different drugs. 
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Some practitioners also mix different drugs in the same syringe.  The sedation 
practitioner must be extremely careful when mixing drugs in the same syringe 
because of possible precipitation.  Independent dosing of drugs is possibly a safer 
option. 
 
During concomitant use of these drugs, patients should be monitored for potential 
CNS and respiratory depression, which are common drug interactions if we do not 
titrate drugs to effect, and know the pharmacodynamics and pharmacokinetics of 
drug used. 
 
The choice of techniques and drugs used for sedation in ambulatory surgery 
should be governed by the principle of minimum intervention.  The dose of any 
drug administered should be the minimum dose necessary to achieve the desired 
effect (Venchard, Thomson and Boys, 2006).  When two or more drugs are 
combined, it is important to be aware of any unforeseen synergistic effects that 
may cause respiratory and/or cardiovascular depression (Myers et al., 2004). 
 
The following is a summary of possible adverse effects when combining drugs for 
procedural sedation. 
 
 Midazolam and ketamine 
 
Parker et al., (1997) found that the combination of midazolam and ketamine 
used independently provides safe and effective sedation for surgical 
procedures in children.  Midazolam provides good anxiolysis and sedation, 
while ketamine provides both sedation and analgesia.  The combination of 
midazolam and ketamine result in a rapid onset of sedation and analgesia, 
less severe dysphoric reactions, and reduce or eliminate cardiovascular 
depressant effects.   
 
A study performed by Luhmann et al., (2006) shows that larger doses of 
both drugs would lead to deeper levels of sedation.  Ketamine would induce 
deeper levels of sedation, good analgesia, and less recall but would cause 
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longer recovery times.  Midazolam was administered intravenously in a 
fixed dose of 2 mg to reduce patient anxiety before ketamine sedation and 
may have contributed to deeper levels of sedation.  Recovery may have been 
slightly longer because of the addition of midazolam. 
 
Adverse events such as ataxia, nightmares, and hallucinations were seen 
with the combination although the administration of midazolam may have 
contributed to a lower incidence.  Vomiting, headaches, and crying were 
also reported before discharge.  A greater incidence of post-operative nausea 
and vomiting (PONV),  reported as 34% in children aged 6 to 10 years old, 
and 32% in children over 11 years old  (Luhmann et al.,  2006).  
 
This is probably one of the highest reported incidences of PONV in 
literature when midazolam and ketamine are combined in children.  It is 
well reported and accepted that higher doses of the two drugs give a higher 
incidence of PONV.  
 
The incidence of PONV was significantly lower in our research study.  An 
oxygen saturation of <93% occurred transiently in 11% of patients who 
received the ketamine and midazolam combination.  This is not a significant 
finding as an oxygen saturation of 93% or above in children is an acceptable 
limit during sedation. 
 
In a study by Roelofse, Joubert and Roelofse (1996), 100 children between 
the ages of 2 and 7 years received either a combination of midazolam (0.35 
mg/kg) and ketamine (5 mg/kg) or midazolam alone (1 mg/kg) rectally.  
Both groups had good sedation and anxiolysis at the time of separation from 
the parents, and immediately before the procedure.  Post-sedation recovery 
was however more rapid after midazolam alone. 
 
Excessive salivation occurred in 26% of children who received ketamine 
and midazolam; 14% in the children who received midazolam alone.  This 
study also found a 14% incidence of hallucinations in children in the group 
that received midazolam alone. 
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Roelofse,  Joubert and Roelofse (1996) reported that there may be a 
correlation between the incidence of hallucinations, and the dose of rectal 
midazolam administered in children. 
 
A later study by Roelofse et al., (2004) demonstrated the safety and efficacy 
of a combination of intranasal ketamine/midazolam.  Key features in this 
study were the ease of administration of drugs, and the rapid onset of action.   
 
It must be realised that the combination of ketamine and midazolam may 
potentially still induce deeper levels of sedation.  The drugs should not be 
used in combination by sedation practitioners not trained in advanced 
sedation techniques. 
 
Cheuk et al., (2005) also demonstrated that the combination of intravenous 
midazolam and ketamine can provide rapid, effective, and safe sedation for 
children who undergo minor operations.  No serious adverse effects were 
seen in the study.  Increased salivation was the most common adverse 
effect.  The median recovery time of 87 min is however quite long since 
adverse effects are usually dose-related, high doses of drugs should be 
avoided.  
 
Titration of intravenous drugs remain the best option to prevent overdose 
and the possibility of respiratory depression.  With procedural sedation there 
is no fixed dose, only a maximum.  
 
In a study done by Roback et al., (2005), respiratory adverse events 
occurred in 10%, vomiting in 5.4% of the patients.   
 
It is well known that the sedative effects of ketamine are synergistic with 
those of benzodiazepines.  It is believed by some clinicians that the 
combination of midazolam reduces the occurrence of hallucinations and 
enhances the quality of ketamine sedation (Oei-Lim, 1997). 
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 Ketamine and propofol (ketofol) 
 
The combination of ketamine and propofol has received interest since the 
early 1990’s as a PSA regimen that allows for the provision of PSA using 
drug doses lower than typically required for each agent alone.  The 
combination, mixed in the same syringe is in use for long time without any 
serious adverse events, when used by skilled sedation practitioners. 
 
Ketofol is a combination of two drugs, ketamine a sedative and analgesic 
drug, propofol a sedative drug, initially used for general anaesthesia. 
 
The two drugs can be administered as a combination in the same syringe, or 
independently in two separate syringes, the one following the other one.  
The way the combination is used depends on the individual preferences of 
the sedation practitioners.  
 
Ketofol can be used as boluses for sedation and analgesia, or as an 
intravenous infusion with different ratios in both adults and children. 
 
Ketamine is known to preserve respiratory drive (protects against 
hypoventilation which is excellent for protecting the airway), and its 
sympathomimetic properties result in an increase in blood pressure.  The 
addition of ketamine provides analgesia that is lacking in a propofol-only 
regimen. 
 
The use of propofol is associated with a dose-dependent risk of respiratory 
depression, a risk that is heightened with concomitant opioid use.  This can 
be problematic for the sedation practitioner wishing to provide analgesia 
with opioids.  It is claimed that when we combine ketamine and propofol 
(ketofol) we need less propofol, and then a lower incidence of respiratory-
related adverse events.  This is what we see in sedation practice. 
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Central nervous system and cardiorespiratory depressant effects may occur 
when propofol is administered with other depressants such as sedative-
hypnotic agents, and narcotic analgesics.  Patients should be monitored 
closely for excessive sedation, and cardiorespiratory depression by the 
sedation practitioner.  Titration of drugs to effect remain the best way to 
prevent adverse events with the administration of drugs. 
 
Literature supports the safe use of  ketofol (Willman and Andolfatto, 2007).  
Ketofol is a very effective and safe combination for PSA in the emergency 
department.  
 
Patients recover quickly after ketofol administration.  The median recovery 
time of 15 minutes in the study by Willman and Andolfatto,  (2007) is an 
example of the excellent recovery characteristics of ketofol. 
 
One can conclude by saying, 
 There is no standard dosing regimen.  Sedation practitioners use 
different ratios and different doses for different procedures. 
 Drugs may be safely premixed in the same syringe or dosed 
sequentially with ketamine administered first to prevent the risk of 
injection-site pain. 
 For short painful procedures usually boluses of ketofol can be used. 
 For longer procedures it is advisable that boluses and a maintenance 
infusion be used. 
 
In children an independent dosing technique is probably better as the level 
of consciousness may change rapidly.  Separating the administration of 
ketamine and propofol may provide the sedation consistency of ketamine 
with the rapid recovery time inherent with propofol boluses. 
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 Midazolam and propofol 
 
It is well known that sedative drugs like midazolam and propofol can 
depress the respiratory system during sedation.  The sedation practitioner 
must understand that the two drugs may cause a synergistic effect.  This 
may even lead to loss of airway control.  It is therefore necessary to titrate 
drugs to effect.  Patients should be monitored closely for respiratory 
depression and possible loss of airway control. 
 
Another possibility to prevent respiratory complications is to use low doses 
of midazolam and propofol as we used in our research study.  Cho, Seo and  
Youn, (2012) report in their study on the combined use of low dose 
midazolam and propofol.  They feel the combination gives a better sedative 
effect compared to midazolam single treatment. 
 
 Midazolam and fentanyl  
 
Drug interactions between opioid analgesics and other drugs are possible for 
example, antidepressants.  The use of fentanyl with selective-serotonin-
reuptake inhibitors may lead to the development of the serotonin syndrome.  
 
Nordt and Clark (1997) report that deaths occurred during the combined use 
of midazolam, and an opioid such as fentanyl.  Midazolam alone produced 
no significant respiratory effects, but when fentanyl is used significant 
respiratory depression can occur.  The combination of midazolam and 
fentanyl was associated with hypoventilation in more than 90% of patients. 
 
In a study done by Roback et al (2005), respiratory adverse events occurred 
in 19.3% of the patients. 
 
Pershad and Godambe, (2004) report that 25% of the patients developed 
hypoxaemia after the administration of midazolam and fentanyl in the 
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emergency department.  Deitch, Chudnofsky and Dominici, (2007) reported 
hypoxemia in 20% of patients. 
 
The study by Khan, Kaul and Neelakanthan, (2010) highlights the 
possibility that midazolam and fentanyl for minor surgical procedures, 
under local infiltration anaesthesia, may produce profound central nervous 
system and respiratory depression with resultant loss of consciousness.  It 
may even be necessary to resuscitate those patients. 
 
Whether one can classify the above adverse events as drug interactions, is 
debatable. What is seen is in effect abnormal responses when we combine 
different drugs. Sedation practitioners need to be very careful when they 
combine different drugs. Patients must be monitored closely. 
 
In this research study the adverse events as described above were not seen.  
This may be because of careful patient selection, skills of the sedation 
practitioner, and titration of drugs used. 
 
3.2.3.4 Adverse events and side effects with the use of single 
drugs 
 
The question is what is an adverse event with sedation.  This is a significant 
issue for sedation practitioners as it may compromise safety.  The World Health 
Organization defines an adverse event (AE) as “any untoward medical 
occurrence that may present during treatment with a pharmaceutical product 
which does not necessarily have a causal relationship with this treatment”  
(Wikipedia, 2014).  An adverse drug reaction is a “response to a drug which is 
noxious and unintended and which occurs at doses normally used in man for 
prophylaxis, diagnosis, or therapy of disease”. 
 
Malviya et al., (2000a) looked at adverse events after patients were 
discharged home.  Patients can be at risk when they return home to an 
unmonitored setting with no person to look after them.  They found a 
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significant incidence of motor imbalance, agitation, and restlessness after 
discharge.  The issue is can we say this is an adverse effect or a side effect.  It is 
clear we as sedation practitioners need to know more about the 
pharmacokinetics and pharmacodynamics of sedative and analgesic drugs. 
 
Motor imbalance was the most frequently reported side effect (Malviya et al., 
2000b).  This shows that we need to inform patients/guardians about this 
side effect as it can last for a few hours.  Agitation or aggressive behaviour 
occurred in 19% of children, and lasted for more than 6 hours in 36% of 
patients.  This is a reasonably common side effect, we are not yet certain of 
the causative factors.  Drugs may play a role here.  
 
Restlessness was significantly related to younger age which is also not 
uncommon.  Other side effects reported include nausea and vomiting and 
diarrhoea (Malviya et al., 2000b).  
 
Maybe we can also classify complications as adverse events as they may 
compromise the safety of the patient. Ceravolo et al., (1986) published a study of 
10,000 patients receiving intravenous sedation in which there were no major 
complications (Giovannitti and Trapp, 1991).    
 
Coplans estimated the mortality rate for parenteral sedation to be around one in a 
million  (Giovannitti and Trapp,  1991).   Mortality has been reported in 0,05% of 
patients, with 60% of this due to hypoxaemia (Quine et al., 1995). 
 
D’Eramo (1999) reported an incidence of 1/6119 patients diagnosed with 
dysrhythmias during conscious sedation.  Phlebitis was relatively common, 
probably caused by intravenous cannulation, occurring in 1/666 patients who 
received parenteral sedation. 
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 Midazolam 
 
Although this research study is not about single drug administration one has 
to look at the possible side effects of single drugs. 
 
The safe use of midazolam is questioned for a long time.  Quine et al., 
(1995) published a study where an operator-sedationist administered 
incremental doses of midazolam intravenously; 13% of patients had oxygen 
saturation levels below 80% in the recovery room following sedation.  
Whether this is a side effect or adverse event is not important.  We know we 
can see this with intravenous midazolam. 
 
The incidence of adverse reactions with the benzodiazepines is usually low.  
Nausea and vomiting, coughing, and hiccoughs have occasionally been 
noted. Respiratory depression may also occur with midazolam but this is 
dose-related in the healthy patients we usually see for sedation.  These 
effects can be reversed with physostigmine administration and with the 
specific benzodiazepine antagonist, flumazenil (Coulthard et al., 2000).  
One must just be very careful if you give the antagonist as you also reverse 
sedation. 
 
When administered in combination with other synergistic drugs or used in 
higher doses, midazolam is likely to result in the loss of upper airway 
muscle tone with possible obstruction.  Children are particularly vulnerable 
to the effect of midazolam and may get respiratory depression with a drop in 
oxygen saturation levels. 
 
Paradoxical reactions have been reported with the use of midazolam.  This 
can be very frustrating for the sedation practitioner.  The patient usually 
becomes agitated, confused, aggressive, and sometimes untreatable.  This 
can occur in 1-7% of patients (Oei-Lim, 1997).  Giving additional doses of 
midazolam in an attempt to control the child or adult usually does not work.  
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It may even be necessary to reverse the action of midazolam with 
flumazenil.  
 
Doyle and Perrin (1994) reported symptoms of emergence delirium after the 
use of intravenous midazolam for conscious sedation. 
 
Wenzel et al., (2002) in a study of 104 patients reported clinically 
significant adverse events with midazolam in six of the patients.  The 
adverse reactions included aggressiveness, euphoria, depression and intense 
hiccups.  It was successfully treated with a titrated dose of flumazenil 0.25 – 
0.5 mg. intravenously. 
 
 Propofol  
 
Propofol rarely causes adverse events when titrated in sedation practice.  
The drug rarely causes postoperative nausea and vomiting.  
 
Propofol is however a controversial drug for use outside the operating 
theatre for those not skilled in airway management.  Deep sedation, airway 
obstruction and respiratory depression can occur rapidly especially with 
bolus doses with resultant hypoxaemia.  
 
Prolonged infusions (longer than 18 hours at more than 4 mg/kg/hour) have 
been associated with fatal metabolic acidosis.  The use of propofol infusions 
in children have been linked with unexplained lactic acidosis, 
hyperlipidaemia, brady arrhythmias, myocardial failure, and even death 
(Wheeler et al., 2003).  This is called the propofol infusion syndrome which 
is not really relevant to procedural sedation.  Sedation practitioners however 
need to be aware of this, especially with a slow pulse for an unexpected 
reason during sedation. 
 
The most common side effect caused by propofol is pain on intravenous 
injection.  It is claimed that it can happen in 31% of patients when using the 
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dorsum of the hand. Leitch, Sutcliffe and  Kenny, (2003) claimed an 
incidence of 20% in patients. When using the vein in the antecubital fossa 
the incidence of pain was 8% (Marinella, 1997).  Pain because of 
intravenous administration of propofol can be very uncomfortable for both 
the patient and sedation practitioner.  It can change the sedation levels of the 
patient and make the procedure uncomfortable. 
 
Several drugs are available to prevent the pain because of propofol 
administration. 10 mg of 1% lidocaine is usually mixed in propofol when 
used for bolus administration or an infusion (Bocian and French, 1992; 
Bryson, Fulton and Faulds, 1995).  It is possible that injection into larger 
proximal veins would prevent this problem  (Smith et al., 1994; Leitch, 
Sutcliffe and  Kenny, 2003 and Rodrigo et al., 2003).  It is claimed that 
ketamine 2mg or tramadol 5mg mixed with propofol can also be used to 
prevent pain. 
 
As previously noted, hypotension can be a side effect.  This is usually 
transient in the healthy patient.  Carefully titrated doses will minimize the 
cardiovascular depression, which is commonly associated with bolus 
injections of propofol (Parworth et al., 1998).   
 
It is postulated that patients talk a lot when they receive propofol for 
sedation.  This is not really a problem in oral surgery, because the nature of 
oral surgery makes it difficult for the patient when the dental procedure is 
being done (Rodrigo and Jonsson., 1989; Rodrigo et al., 2003).  We 
sometimes do see talking after propofol before the dentist start doing the 
procedure.  This sometimes happens when patients are taking 
antidepressants. 
 
Rodrigo et al., (2003) and Girdler et al., (2000) reported an incidence of 
75% of anterograde amnesia in patients that receive propofol.  This is hard 
to believe.  Although propofol can cause amnesia we usually see this with 
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high doses after general anaesthesia.  Not much is published on the amnesia 
effect of propofol. 
 
Neuroexcitatory events, such as tremors, twitching, and hiccups, have been 
reported (Cockshott et al., 1987).  This is not something we see with 
procedural sedation, but is possible with general anaesthesia in the period 
before the patient becomes unconscious.  
 
Hallucinations have been described with propofol use (Nelson, 1988). We 
do not see this with procedural sedation. 
 
Anaphylaxis has been reported during use with propofol.  It is however 
difficult to say whether this hypersensitivity is due to the drug propofol or to 
the lipid vehicle (Laxenaire et al., 1988; Laxenaire et al., 1992; McHale and 
Konieczko, 1992).  
 
It is advised in sedation practice that if there is an allergic reaction to 
propofol it should not be used in those with a history of egg allergy. 
 
 Ketamine 
 
Ketamine has become one of the most significant drugs in sedation practice 
as it a sedative and analgesic. 
 
Side effects because of ketamine administration are of concern.  This 
usually happens when large doses of ketamine are used, not with smaller 
doses.  
 
The most common side effect is probably hallucinations, which can be 
uncomfortable.  It is interesting to note that this is usually not a serious 
complication in children (2% incidence) as the hallucinations are not of an 
aggressive character.  This is more often (up to 30% incidence) seen in 
adults.  Risk factors for emergence reactions have been described as:  
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 age over 15 years,  
 female gender,  
 a history of vivid dreams, and  
 personality or psychiatric problems.  
 
Midazolam can be co-administered (0.05–0.2 mg/kg orally) to reduce the 
incidence of hallucinations. 
 
Roback et al., (2006) reported an incidence of vomiting of 26.3% when 
ketamine was administered via the intramuscular route as to an 11.9% 
incidence with the intravenous ketamine route. 
 
Other side effects reported are increased salivation, purposeless movements, 
and agitation (Hollister and Burn, 1974).  Whether this is important in 
sedation practice can be debated.  It is generally accepted that with low 
doses of ketamine there is a low incidence of side effects.  
 
 Fentanyl 
 
Fentanyl can cause respiratory and cardiac depression, particularly in 
combination with other respiratory depressant drugs.  Van Leeuwen, Deen, 
and Helmers, (1981) reported that respiratory depression had to be reversed 
in 51% of the fentanyl group who received sedation.  This incidence is 
indeed high, and not seen during our study.  One probably has to accept that 
this is a side effect, and that fentanyl should be titrated to effect. 
 
Fentanyl can cause muscle rigidity which is probably dose-dependent 
(Koska, Romagnoli and Kramer, 1981).  We rarely see this in sedation 
practice with the small doses we use. 
 
The most common adverse effect of fentanyl is probably nausea, also rarely 
seen in sedation practice with small doses of the drug used (Mayes and 
Ferrone, 2006). 
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3.3 COST-EFFECTIVENESS OF SEDATION 
Previously the only option available to the dentist was the use of general 
anaesthesia in order to perform especially difficult or lengthy dental procedures.  
This mode of treatment has been proven to be costly, and conscious sedation has 
become a viable choice as an alternative to general anaesthesia for sedation 
procedures.  The challenge to the dentist with conscious sedation is to find 
effective ways of behavioural management when a child is not made unconscious 
as with general anaesthesia (Naidoo, 2004). 
Various studies assessed the aspect of cost and tried to relate it to an assessment 
criteria formula.  One asks oneself whether this would be practical.  The following 
is a business definition of cost-effectiveness: 
“It involves the offering of the maximum benefit for a given level of expenditure. 
When limited resources are available to meet specific objectives, the cost-effective 
solution is the best that can be achieved for that level of expenditure, and the one 
that provides good value for money” (BNET Business Dictionary, 2010). 
Whether the above is so easy to use as a tool for cost-effectiveness is difficult to 
answer.  It is probably not practical. 
Society is confronted with many difficult choices in the provision of health care 
services, and public health programs.  To make informed choices, we need 
information about the impact of services and programs, their costs, and the 
consequences of choosing one option over another.  One tool available for this 
objective is called the cost-effectiveness analysis (Edejer et al., 2003).  Naidoo 
(2004) did a retrospective study on patients aged 12 months to 12 years treated for 
dental procedures under general anaesthesia or conscious sedation.  He analysed 
the results of 140 patients treated under general anaesthesia, and 140 patients 
treated under conscious sedation.  Only healthy patients with an ASA I or ASA II 
classification were included in this study to compare the cost-effectiveness of 
sedation and general anaesthesia.  The overall costs of the procedures were lower 
in the conscious sedation group. 
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Smith (2004) did a comparative study of the costs involved in general anaesthesia 
versus conscious sedation in dental surgery.  Twenty-six patients were done under 
general anaesthesia, 24 patients had conscious sedation for dental surgery.  The 
costs of drugs, disposable items, as well as theatre fees were evaluated.  The costs 
involved for each individual case one was calculated separately. The average age 
of the patients receiving general anaesthesia in the study was 12.2 years, the 
average age of the patients receiving conscious sedation was 30.1 years.  The 
average duration of the procedure for general anaesthesia was 45.88 mins/patient 
which translate to a cost of R5.74/min/patient. 
In the conscious sedation group the average time for sedation was 28.70 
mins/patient which translate to a cost of R2.37/min/patient.  The results of this 
study, although a small number of patients, show that the costs for conscious 
sedation are considerably less than those for general anaesthesia.   
Lee, Vann and Roberts, (2001) did an interesting study.  They compared the cost 
of general anaesthesia with that of oral conscious sedation for paediatric sedation.  
This was done in 22 children aged 24 – 60 months. 
The results show that if a children need more than three sessions under conscious 
sedation for dental procedures, then general anaesthesia is possibly a more cost-
effective option. 
Ashley et al., (2009) reviewed the literature as to cost effectiveness of sedation 
versus general anaesthesia.  Their findings show that general anaesthesia was 
46.6% more expensive than conscious sedation.  
Dental treatment under sedation may require several visits especially with lengthy 
procedures.  Patients may become uncomfortable to be in the dental chair for long 
procedures.  This is usually not the case for dental treatment under general 
anaesthesia as there is not really a time limit.  It happens rarely that sedation may 
fail but it is a possibility.  In that case a patient may need general anaesthesia 
which will lead to an escalation in costs. Van Sickels and Tiner, (1992) reported 
that it was twice as expensive to undergo genioplasty in an outpatient surgical 
suite under general anaesthesia than in a private office under intravenous sedation. 
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The following research studies were not done under sedation for dental 
procedures. They however do highlight the fact that sedation is a cost-effective 
alternative for general anaesthesia also for medical procedures.  
Squires et al., (1995) compared intravenous sedation and general anaesthesia with 
regard to efficacy, safety and cost in young patients undergoing endoscopic 
procedures.  The average charges were $768.52 in the intravenous sedation group, 
versus $1,965.42 in the general anaesthesia group.   
Jameson et al., (2007) reported that the average cost per child treated with 
combinations of drugs, as in our research study for example, midazolam and 
fentanyl was £245.47, whereas the average cost of general anaesthesia was 46.6% 
more.  From the above information on studies done by different researchers it is 
clear that the cost for sedation is significantly less than the cost of general 
anaesthesia for procedures outside the operating theater. 
It must however be emphasized that not all procedures qualify for sedation outside 
the operating theater.   
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CHAPTER 4:  STUDIES TO DETERMINE THE SAFETY 
AND EFFICACY OF CONSCIOUS SEDATION OUTSIDE THE 
OPERATING THEATER 
4.1 An evaluation of Post Sedation Satisfaction in children. 
4.1.1 Introduction 
Intravenous sedation was used to control pain and anxiety for dental procedures 
on children during this study.  Sedation was preferred to general anaesthesia as 
theatre capacity is limited with long waiting lists, cost-effectiveness, and the 
lower incidence of side-effects in sedation.  
To choose the right drugs in children is extremely important.  Drugs influence the 
level of consciousness which may influence morbidity and adverse events during 
and after sedation.  Children often slip inadvertently into deeper levels of sedation 
during conscious sedation and the sedation practitioner must be aware of this. 
According to the 2015 SASA guidelines on Procedural Sedation and Analgesia 
(SASA, 2010; SASA, 2015) the level of consciousness must meet the demands for 
safe practice; children must be able to communicate and respond to verbal 
command or light tactile stimulation, and the protective reflexes coughing and 
swallowing must be intact. 
As sedation practitioners we use subjective rating scales to determine the level of 
consciousness (sedation) as objective monitors for example, the BIS (Bispectral 
Index Monitor) are extremely expensive and not readily available in developing 
countries in the world.  For subjective monitoring we use either the UMSS 
(University of Michigan Sedation scale) or the Wilson scale (SASA, 2015) as they 
are easy to use and understand.  The level of consciousness must be documented 
on a sedation flow sheet during and after sedation (Appendix 1). 
Parents received a post-sedation questionnaire to fill in at home as to patient 
satisfaction and the incidence of side-effects, and to rate the sedation technique. 
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The parents gave valid informed consent for the procedure and sedation, and to 
supply this information. 
4.1.2 Aims of the study 
The aims of this study were 
to determine whether the combination of midazolam,  ketamine and propofol,  that 
is called an advanced sedation technique (SASA, 2010),  can be safely used for 
paediatric sedation during dental procedures outside the operating theatre 
to evaluate the side-effect profile after conscious sedation using multiple drugs. 
Here we had to rely on the parents to give us most of the information. 
It is known that there is a high incidence of  side-effects for example,   PONV, 
after general anaesthesia.  It is postulated that there is a low incidence of side – 
effects after conscious sedation (PSA). 
4.1.3 Objectives of the study 
This study was designed with the following specific objectives: 
To assess safety of discharge by measuring the state of mind (recovery) on 
departure 
To assess state of mind on arrival home, and after 4, 8, 12 and 24 hours post-
operatively 
To evaluate side-effects during the journey home (after discharge) as this may 
lead to morbidity and anxiety of the children and parents,  and a negative attitude 
towards future use of conscious sedation 
To evaluate side effects on arrival home, and after 4, 8, 12 and 24 hours post-
operatively 
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To evaluate the level of consciousness (LOC) during the journey.  This is an 
extremely important point as children may slip into deeper levels of sedation and 
airway obstruction is a real possibility. 
To evaluate the level of consciousness (LOC) on arrival home, and after 4, 8, 12 
and 24 hours post-operatively 
To evaluate recollection of children of the dental procedures during sedation on 
arrival home, and after 4, 8, 12 and 24 hours post-operatively. 
To assess satisfaction of patients after sedation with a visual analogue rating scale.  
Post-sedation satisfaction is an important aspect of evaluation of the acceptability 
of patients of conscious sedation as an alternative to general anaesthesia.  It is also 
expected that sedation practices must undergo a regular, robust audit as part of 
clinical governance. 
4.1.4 Materials and methods 
One hundred children aged 3-9 years were entered into this study (≤12 years old 
as this age group is defined as children) done at the Faculty of Dentistry, 
University of the Western Cape, Cape Town.  Written valid informed consent 
(Appendix 5) was routinely obtained from a parent for the procedure and sedation, 
and to fill in the post sedation questionnaires (Appendix 10).  Only ASA I and II 
children were accepted for the study.  Children were examined for any disease, 
especially upper respiratory signs and symptoms, before administration of any 
drugs.  A focused airway examination was done in all children. 
Children also received an EMLA® patch on the dorsum of the hand to 
anaesthetize the skin for cannulation of a vein.  A 24-gauge cannula was used in 
all children and kept in situ for the duration of the procedure, and until discharge.  
A professional nurse with airway certification, and part of the sedation team,  
helped with continuous monitoring of blood pressure, ECG, O2  saturation, 
respiratory rate, and pulse rate for the duration of sedation and the recovery 
period. 
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In this study three intravenous drugs midazolam, ketamine and propofol, were 
used in separate syringes.  Doses and tables of individual drugs were discussed in 
Chapter 3 (Appendix 9). 
Midazolam in children has a rapid onset administered intravenously and should be 
titrated to response.  The drug has anxiolytic, sedative, amnestic and 
anticonvulsant properties, but unfortunately no analgesic effects. 
Ketamine is a dissociative anaesthetic agent used for conscious sedation.  It has 
become a very popular drug administered as independent dosing or in 
combination with other drugs for example, ketofol, who is a combination of 
ketamine and propofol.  It has unique properties and provides sedation, analgesia, 
a stable cardiovascular and respiratory systems, and the protective reflexes are 
intact. 
Propofol is an anaesthetic drug used for intravenous sedation.  It has a rapid onset 
of action, provides rapid recovery but has no analgesic properties.  There is also 
no antagonist available to reverse its action. 
A combination of ketamine and propofol (Ketofol) used in the same syringe for 
sedation has become very popular.  It is believed that the combination allows us to 
use reduced doses of both drugs with a lower incidence of side effects. 
A sedation flow chart was used to record all information regarding drug 
administration, doses, vital signs, and discharge readiness as per SASA 
Guidelines on Procedural Sedation for Children (SASA, 2010).  The starting time 
of starting sedation, length of the procedure duration, and end time of the 
procedure till the patient discharge were recorded. 
Children were only discharged from the sedation facility when they met the 
discharge criteria according to the Aldrete recovery scale (SASA, 2015) and 
accompanied by a responsible adult.  
Before discharge, parents/escorts received a post sedation questionnaire (PSQ) 
(Appendix 10) to fill in at home.  The form was explained to them.  The purpose 
of the PSQ was to gather information regarding recovery, possible side-effects, 
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behaviour of the children, and an evaluation of the sedation technique by the 
parent/escort (Appendix 10). 
The information (Appendix 10) gathered included the following:  
 the state of the mind on departure for example, happy, indifferent, weeping 
or agitated;  
 drug side-effects during the journey for example, nausea, vomiting, a 
combination of nausea and vomiting, headaches, blurred vision and 
restlessness; 
 the state of mind, level of consciousness, drug-side effects and memory of 
the procedures on arrival home, and after 4,  8, 12, 24 hours. 
 parents were also asked to rate their overall satisfaction with the sedation 
experience using a 1 to 10 visual analogue scale (Poor to Excellent) 
(Appendix 10). 
4.1.5 Statistical analysis of results 
The data were captured and stored in an Excel ® spreadsheet.  Certain basic 
statistics were calculated and the data were also used for various graphical 
representations as summaries.  Tests of association between class variables were 
performed by obtaining contingency tables and applying the chi-squared test; 
where the frequencies in the tables were small the Fisher exact test was used to 
verify the results indicated by the chi-squared test. 
4.1.6 Results 
One hundred children aged 3-9 years, and their parents were approached to 
consider participation in this study.  Data from one hundred children were 
included in the final analysis.  A combination of midazolam, propofol and 
ketamine was used in all the patients.  Figure 1 shows the age distribution of the 
children. 
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Figure 1.  Age distribution 
 
4.1.6.1 The state of mind on departure 
Figure 2 shows that the majority of the patients (86%) were happy on departure.  
The percentages of patients in the different categories evaluated are shown in 
Figure 2,  95% confidence limits are in brackets: Happy = 86% (78-92),  
Indifferent = 27% (19-37),  Weeping = 14% (8-22),  Agitated = 9% (5-16). 
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Figure 2. State of mind on departure 
 
4.1.6.2  State of mind on arrival home, and after 4, 8, 12 and 24 hours 
 
Assessments of children being indifferent, weeping and agitated after 8 hours are 
shown in Figure 3.  A high percentage of children were happy on arrival 24 hours 
after the sedation experience. 
 
This is a significant finding as to the safety and efficacy of the sedation technique 
and the way children were treated during their stay at the clinic. 
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Figure 3.    State of mind on arrival home,  and after 4, 8, 12 and 24 hours 
 
 
4.1.6.3  Monitoring of side-effects during the journey, on arrival 
home, and after 4, 8, 12 and 24 hours 
 
All the side effects that occurred are presented in Figures 4 and 5.  Restlessness 
and blurred vision were present in 29% and 16%   respectively.   After 8 and 12 
hours the number of patients with restlessness came down to 5 and 2.  After 24 
hours only one patient presented with restlessness, blurred vision and headache. 
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Figure 4.   Drug side effects during journey (after discharge) 
 
 
Figure 5.    Side effects on arrival home, and after 4, 8, 12 and 24 hours 
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4.1.6.4  To monitor the level of sedation during the journey, on arrival home  
and after 4, 8, 12 and 24 hours 
 
Figure 6 shows that 69 people felt awake and orientated during the journey home, 
84 felt awake and orientated on arrival (Figure 7) and a high percentage of 
respondents were awake and orientated 24 hours after arriving home.  The number 
of patients experiencing drowsiness show a downward trend from arrival home to 
24 hours after arrival home. 
 
Figure 6.  Level of sedation during journey 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70 
 
Figure 7.   Level of sedation on arrival home and after 4, 8, 12 and 24 hours 
 
 
 
4.1.6.5   To test memory of procedures on arrival home, and after 
4, 8, 12 and 24 hours 
 
     
The memory of the procedures on arrival home in Figure 8, for example, 
injection in the gum, discomfort and pain during treatment, were noted in a small 
number of patients.  This showed that the sedation procedure was comfortable 
and successful as far as patient satisfaction is concerned.  A significant number 
of patients remembered the cannulation experience on the back of hand.  This 
was expected as some children do remember experiences like this even when an 
amnesic sedative is administered. 
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Figure 8.   Memory of procedures on arrival home and during 
 the 24 hour period after arrival home 
 
 
 
4.1.6.6 Assessment of patient satisfaction after sedation with the 
visual analogue rating scale 
 
The majority of patients (90%) gave a satisfaction rating of 7-10 on the visual 
analogue scale of 1 to 10 where 1= poor and 10 equals excellent (Figure 9). 
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Figure 9.    Satisfactory rating of satisfaction of children after sedation 
 
 
The following tables represent the side-effect profile of the children during the 
journey home, and at home.  The 2x2 tables and chi-square test were used to 
evaluate the association between the level of sedation state of mind, (Table 8 to 
Table 10) and drug side effects (Table 11 and Table 12). 
 
The proportion of patients who were not drowsy during the journey and happy on 
arrival (46/50=0.92) is significantly greater than the proportion who were drowsy 
during the journey, and happy on arrival home (36/50=0.72): chi squared = 5.488, 
df = 1, p-value <0.05 (Table 8). 
 
Table 8.    Drowsy during journey and happy on arrival home 
  
Happy on arrival home 
No Yes Total 
Drowsy during 
journey 
No 4 46 50 
Yes 14 36 50 
Total 18 82 100 
 
The proportion of patients who were not drowsy during the journey, and 
indifferent on arrival (5/50=0.10) is significantly than the proportion who were 
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drowsy during the journey, and indifferent on arrival home (16/50=0.32):  chi-
squared = 6.0277, df = 1, p-value <0.05 (Table 9). 
 
Table 9.   Drowsy during journey and indifferent on arrival home 
  
Indifferent on arrival home 
No Yes Total 
Drowsy during 
journey 
No 45 5 50 
Yes 34 16 50 
Total 79 21 100 
 
The proportion of patients who were not drowsy during the journey and agitated 
on arrival home (48/50=0.96) is significantly greater than the proportion who 
were drowsy during the journey and not agitated on arrival home (40/50=0.80):  
chi-squared = 4.6402, df = 1, p-value <0.05 (Table 10) 
 
Table 10.    Drowsy during journey and agitated on arrival home 
  
Agitated on arrival home 
No Yes Total 
Drowsy during 
journey 
No 48 2 50 
Yes 40 10 50 
Total 88 12 100 
 
 
The proportion of patients who were not nauseous during the journey and not 
nauseous on arrival home (93/95=0.98) is significantly greater than the proportion 
who were nauseous during the journey and not nauseous on arrival home 
(3/5=0.60):  chi-squared = 9.2654, df = 1, p-value = <0.05.) (Table 11). 
 
Table 11.   Nausea during the journey and nausea on arrival home 
  
Nausea on arrival home 
No Yes Total 
Nausea during the 
journey 
No 93 2 95 
Yes 3 2 5 
Total 96 4 100 
 
The proportion of patients who were not nauseous during the journey and not 
nauseous at 8 hours after arrival (94/95=0.99) is significantly greater than the 
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proportion who were nauseous during the journey and not nauseous at 8 hours 
after arrival home (3/5=0.60): chi-squared = 13.185,  df = 1,  p-value = <0.05 
(Table 12) 
 
Table 12.  Nausea during the journey and nausea after 8 hours 
  
Nausea after 8 hours 
No Yes Total 
Nausea during the 
journey 
No 94 1 95 
Yes 3 2 5 
Total 97 3 100 
 
The  gender distribution is f=49, m=50( one missing value) 
 
The analyses reported in Tables 8-12 were repeated separately for Males and 
Females. It turned out that the results for Females were almost exactly like those 
for the whole group, that is, so far as statistical significance went, but all tests of 
association gave non-significant results for Males. So it appears that the 
differences seen in Tables 8-12 are due to differences in the Female responses. 
 
4.1.7 Discussion 
 
The three drugs midazolam, ketamine and propofol were used as a combination in 
all the children.  Our data showed that the common side effects on arrival home 
were restlessness (29%), blurred vision (16%), nausea (7%), vomiting (2%) and 
headaches (4%). 
 
The incidence of drowsiness was 45% which can be seen as a side-effect but this 
is usually expected with administration of sedative drugs to cause anxiolysis.  The 
numbers 50 and 50 in the last columns of Tables 8, 9, 10 are marginal totals in 
every case referring to the classificatory variable Drowsy during journey.  
Drowsiness is seen as an indication that patients are starting to relax and that we 
may proceed with the procedure. 
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After 8 to 12 hours the incidence of restlessness (5%) and blurred vision (2%) 
decreased.  The number of patients with restlessness came down to 5 and 2 
respectively and blurred vision to 1% after 8 and 12 hours. 
 
Fifty percent of the children were drowsy during their journey home.  On arrival 
at home 35% of children were still drowsy, and only 1% at 24 hours. 
 
Wood (2013) reported the incidence of nausea in 5 to 10% of patients after 
ketamine administration.  The combination of midazolam and ketamine showed 
an incidence of vomiting in 9%, and agitation in 5.4% of children. (Ozdemir et al., 
2004).   
 
Wathen et al., (2000) reported agitation in 5.7% of patients after ketamine 
administration for sedation, and 35.7% in patients after the administration of a 
combination of ketamine and midazolam.  Vomiting occurred in 10.1% of 
children after ketamine administration, and 5.4 % after a combination of ketamine 
and midazolam. 
 
The literature (Table 13) shows that the incidence of side effects after the 
administration of a single drug during sedation is almost the same as when drugs 
are combined.  Our research study shows the same incidence of side effects when 
using the combination of midazolam, ketamine and propofol (Table 14). 
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Table 13.    Drug administration and side effects 
                    during procedures 
Reference Drugs Side effects 
  Nausea Vomiting 
Wood, (2013) Ketamine 5-10% 
Roback et al., 
(2005) 
Midazolam  0.8% 
Ketamine  10.1% 
Ozdemir et al., 
(2004) 
Midazolam  5.4% 
Ketamine  9.0% 
Wathen et al.,  
(2000) 
Midazolam  
9.6% 
Ketamine  
Kennedy et al., 
(1998) 
Midazolam  
7.7% 
Ketamine  
Wathen et al., 
(2000) 
Ketamine  19.4% 
 
The 2X2 tables showed significant associations between levels of sedation, state 
of mind, and drug side effects during the journey and on the way home. 
  
Table 14.   Drug administration and side effects during the journey, on 
                   arrival home and 24 hours after arrival home 
 
Side effects 
During 
the 
journey 
On 
arrival 
home 
After 
 4 
hours 
After  
8  
hours 
After 
12 
hours 
After 
24 
hours 
Nausea 7% 4% 7% 3% 3% 2% 
Vomiting 2% 3% 2% 2% 2% 2% 
Drowsiness 50% 35% 15% 4% 2% 2% 
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4.1.8 Conclusion 
 
The research study shows that side effects are present after using sedative drugs 
for procedural sedation.  The sedation practitioner must be aware of this and also 
inform the parents of this possibility.  
 
It is evident that intravenous sedation with midazolam, ketamine and propofol is 
safe and effective to use during sedation procedures.  There may be side effects 
but they are not long lasting. 
 
4.2 An evaluation of Post Sedation Satisfaction in adults 
 
4.2.1 Introduction 
 
Side effects after sedation procedures in a hospital setting have been reported in 
previous studies.  Data referring to side effects after discharge home are limited 
(Malviya et al., 2000a).  This is concerning as adverse events may occur when 
patients are going home.  Patients may be at risk on the way home because of lack 
of monitoring, but also because patients are not informed of this possibility.   
 
Delayed recovery, a possible side effect, can be caused by excessive doses of 
drugs not titrated to effect, and using the wrong combination of drugs. 
Nausea and vomiting can be caused by the administration of certain drugs for 
example, the opioids, and ketamine. 
 
The purpose of this study, was to determine post sedation recovery on arrival 
home, as well as the relationship between side effects and dental procedures 
sedation.  
 
While conscious sedation is generally well-tolerated, certain side effects may be 
noticed for several hours after the procedure.  This is very important to understand 
as it is possible that the deeper the level of sedation the higher the incidence of 
side effects (Coplans and Curson, 1982). 
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Luhmann et al., (2006) reported side effects such as ataxia, nightmares, 
hallucinations, vomiting, headaches and crying after sedation before discharge.  
 
Oxygen saturation levels of <93% occurred in 11% of patients who received the 
ketamine and midazolam combination.  
 
Luhman et al., (2006) reported a higher incidence of post-operative nausea and 
vomiting (PONV) in paediatric patients.  The incidence of PONV was reported as 
34% in children aged 6 to 10 years, and 32% in children older than 11 years. 
 
The sedative effects of ketamine are synergistic with those of the 
benzodiazepines. Titration still remains the best option to combine the two drugs.  
It is reported that the use of midazolam with ketamine reduces the incidence of 
hallucinations, and enhances the quality of ketamine sedation (Oei-Lim, 1997).  
Roback et al., (2005) reported an incidence of PONV of 5.4% in their study.  
 
Hypoxaemia can be an adverse event, or even called a side effect, during sedation, 
this usually due to the drugs that depress the respiratory centre.  This is the reason 
why we advise sedation practitioners to titrate sedative drugs to effect.  
 
Mortality is rare during sedation when all the requirements of safe practice are 
met. Nordt and Clark (1997) reported that deaths occurred during sedation with 
the combined use of midazolam and an opioid fentanyl.  This should not happen 
when drugs are titrated during sedation.  Midazolam alone in their study did not 
produce significant respiratory depression.  Fentanyl alone caused significant 
drops in oxygen saturation levels. 
 
Pershad and Godambe (2004) reported a 25% incidence of drop in saturation 
levels after the administration of midazolam and fentanyl for orthopaedic 
procedures in the emergency department.  The American College of Emergency 
Physicians (2005) reported a 20% incidence of drop in saturation levels in patients 
receiving midazolam and fentanyl.  
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The incidence of drops in oxygen saturation levels, as reported above, are high.  
One would expect the figures to be lower.  However it illustrates a very important 
point, and that is that drugs can cause respiratory depression.  Patients need to be 
monitored continuously. 
 
The level of consciousness should be carefully monitored and documented 
continuously on a Sedation Scoring System (Appendix 1). The level of sedation 
can have a direct influence on recovery characteristics.  The deeper the sedation 
level the longer it may take for the patient to recover.  This is not an ideal situation 
for out of hospital sedation. 
 
Four sedative/analgesic drugs namely midazolam, propofol, fentanyl and ketamine 
were used in this research study.  The synergistic effects of the drugs may lead to 
deeper levels of sedation and prolonged recovery.  There may also be a higher 
incidence of adverse events.  The ideal is to titrate drugs to effect. 
 
4.2.2 Aims of the study 
 
The purpose of this study was to evaluate the safety and efficacy and side effect 
profile of an advanced sedation technique (combining different drugs) in adult 
patients.  
 
4.2.3 Objectives of the study 
 
This research study was designed with the following objectives in mind: 
 To evaluate the incidence of sedation-related side effects on arrival home 
after administration of combinations of drugs. 
 To assess the possible association between the incidence of side effects and 
specific dental procedures. 
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4.2.4 Materials and methods 
 
Sedation was administered to 447 ASA I and II male and female adult patients 
(aged 18 years and older) by the sedation practitioner on duty in the sedation 
facility of the Faculty of  Dentistry.  Valid written informed consent was obtained 
from all sedation patients.  
 
All the patients had an intravenous cannula in placed in a vein on the dorsum of 
the hand for the duration of the procedure and recovery.  
 
In addition to the dedicated sedation practitioner a nurse helped with monitoring 
of the haemodynamic parameters. 
 
The following drugs were used in this study, midazolam, propofol, fentanyl, and 
ketamine.  A Sedation Monitoring Chart (Appendix 4) was used to document all 
the information.  The time of onset of sedation, length of the procedure and 
sedation and time from the end of the procedure to patient discharge were 
recorded.  The patients were discharged from the sedation facility only when they 
met the discharge criteria (Appendix 6). 
 
Before discharge, the patient, and escort received a questionnaire (Appendix 11) 
to fill in which consisted of 37 questions related to the patient’s experience of the 
sedation procedure as well as experience of the patient after reaching home.  The 
questionnaire was to be completed at home over the next 24 hours. This 
questionnaire had to be returned at the follow-up of the patient. 
 
Of particular importance to us was the experience of the patient during and after 
sedation, especially the side-effect profile, and how they rated the whole process 
of sedation and surgery. 
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4.2.5 Statistical analysis of results 
 
The data were recorded in an EXCEL spreadsheet manner suitable for statistical 
analysis, and the analyses were performed using the program R (R Core Team 
(2014).  The incidence of various side effects was estimated in the usual way by 
the sample proportions, and associated 95% confidence limits were obtained.  
Associations between side effects and dental procedures were examined by 
drawing up appropriate contingency tables and applying the chi-squared test 
procedure.  
 
4.2.6 Results  
 
Four hundred and fourty seven (447) patients participated in this study.  A 
summary of all side effects, as well as the results of the side effects related to the 
different dental procedures, and the results of the chi-squared tests can be seen in 
Table 15.   The number of patients with vomiting and described as “other” in the 
table were insignificant and were not statistically evaluated. 
 
Interesting results were the statistical significance related to drowsiness and the 
dental procedure (p<0.006).  There was also a statistical significance between 
swelling and certain dental procedures (p<0.002) (Tables 15).  The association is 
difficult to explain.  
 
 Incidence of side effects 
 
Results are summarized in Table 15.  The first column of the table gives a list 
of dental procedures, the first row a list of recorded side effects.  The row 
labelled Overall gives the percentage of patients who experienced the side 
effect listed in the relevant column, for example, an estimate of the prevalence 
(incidence?) of Drowsy.  The rows labelled Low and High give the lower and 
upper limits of a 95% confidence interval for the prevalence.  For example, of 
the 447 patients 245 recorded Yes for Drowsy, for example, 54.8%, and this is 
taken as the estimate of the prevalence (incidence?) of this side effect in the 
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population.  In summary, the estimate of prevalence of Drowsiness is 54.8% 
with 95% confidence limits (50.5%, 59.5%). 
 
The same explanation applies to the other side effects. 
 
Table 15.   Summary of side effects related to dental procedures and 
results of chi-squared tests 
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None 9 44.4 11.1 0 0 11.1 0 22.2 11.1 22.2 11.1 22.2 0 
Peri Gum 45 51.1 17.8 2.2 0 11.1 11.1 17.8 24.4 24.4 8.9 22.2 22.2 
Prost 87 59.8 25.3 4.6 0 5.7 8.0 6.9 10.3 11.5 14.9 16.1 0 
Implant 137 42.3 19.0 5.8 1.5 8.8 8.8 23.4 10.9 26.3 19.0 23.4 3.6 
Endo 29 62.1 24.1 0 0 0 0 0 10.3 20.7 6.9 17.2 3.4 
Extract 58 65.5 24.1 3.4 1.7 10.3 12.1 25.9 22.4 22.4 13.8 15.5 1.7 
Oral 
Surgery 
7 28.6 28.6 14.3 0 14.3 0 42.9 28.6 0 28.6 14.3 0 
Multiple 75 66.7 28.0 8.0 2.7 9.3 12.0 22.7 14.7 24.0 17.3 30.7 1.3 
              
Overall  54.8 22.6 5.2 1.1 8.3 8.9 18.6 14.5 21.5 15.4 21.5 2 
Low  50.1 18.8 3.3 0.4 5.9 6.5 15.1 11.4 17.8 12.2 17.8 0.9 
High  59.5 26.8 7.6 2.6 11.2 12.0 22.5 18.2 25.6 19.1 25.6 3.8 
Chisq  19.61 4.18 6.03  4.73 6.32 22.23 10.71 9.49 5.81 7.3  
P  0.006 0.759 0.534  0.693 0.503 0.002 0.152 0.219 0.562 0.398  
 
The incidence of side effects in Table 15 is the experience of patients over a 24 
hour period. An interesting side effect is the disturbances of sleep pattern 
(15.4%) which may be related to their pain experience, which is reported as 
14.5% by the patients. The high incidence of drowsiness (54.8%) is important 
for us as sedation practitioners.  
 
There is a low incidence of nausea (5.2%).  The term “emotional fragility” (felt 
down) is difficult to define; it looks like patients may be depressed after the 
operation but this was not investigated further. 
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 Association between the incidence of  side effects  and specific dental 
procedures 
 
Table 16 shows a cross tabulation of patients according to Drowsiness and 
Procedure.  For example, there were 137 patients with procedure=Implant, of 
these 58 recorded Drowsiness=Yes. 
 
The hypothesis under test here is H0=the probability of Drowsiness=Yes is 
identical for all of the Dental Procedures.  The chi-squared test applied to the 
8×2 contingency table represented by the second and third columns of Table 16 
is suitable for testing H0.  The result is: observed chi-squared = 19.61, df.=7, 
P=0.006, indicating rejection of H0. Inspection of differences between observed 
frequencies and expected frequencies under H0 shows that the incidence of 
Drowsiness at Procedure=Implant is significantly low, at Procedure=Multiple it 
is significantly high. 
 
In Table 15 the column headed Drowsy is a brief summary of the results 
discussed above.  It contains Percent Yes, and in the rows labelled chi-squared 
and P the values 19.61 and 0.006 for observed chi-squared and P. 
 
Examination of Table 15 shows that the results of only one other side effect, 
namely Swelling, produced a statistically significant observed chi-
squared=22.23, P=0.002. Further examination of observed and expected 
frequencies shows that the percentage Yes is significantly low for Dental 
Procedure= Prost and Endo. 
 
Table 16.   Incidence of drowsiness and individual procedures 
 
PROCEDURES DROWSINESS 
 None Yes Total Percent Yes 
None 5 4 9 44.4 
Peri Gum 22 23 45 51.1 
Prost 35 52 87 59.8 
Implant 79 58 137 42.3 
Endo 11 18 29 62.1 
Extract 20 38 58 65.5 
Oral Surgery 5 2 7 28.6 
Multiple 25 50 75 66.7 
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The incidence of swelling and individual procedures performed are shown 
in Table 17.  
 
 
Table 17.    Swelling and individual procedures 
 
PROCEDURES SWELLING 
 No Yes Total Percent Yes 
None 7 2 9 22.2 
Peri Gum 37 8 45 17.8 
Prost 81 6 87 6.9 
Implant 105 32 137 23.4 
Endo 29 0 29 0.0 
Extract 43 15 58 25.9 
Oral Surgery 4 3 7 42.9 
Multiple 58 17 75 22.7 
 
 
The above is just an interesting observation but not really significantly 
relevant to safety of conscious sedation  
 
4.2.7 Discussion 
 
The drugs midazolam, propofol, fentanyl and ketamine were used in all the 
patients.  Muhammad and Siddiqui (2011) reported a 11% incidence of 
drowsiness in the recovery room one hour after surgery when midazolam was 
used for sedation.  
 
Our data demonstrates that drowsiness (54.8%) was a significant side effect in 
patients on arrival home after sedation.  This may not be such an important side 
effect, but it shows that patients be cautioned about for example, driving a motor 
car within 24 hours after sedation.  
 
What is very significant is that only 5.2% of patients experienced nausea/sick 
feeling after sedation.  This is a significant finding as patient satisfaction is an 
important component of sedation practice, and will become more so in future as 
sedation is a fast growing option for patient care.  
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McGlone, Howes and Joshi, (2004) reported that 70% of patients vomited in 
recovery or at home following the administration of intramuscular ketamine to 
310 children.  This is an expected finding as it is well known that intramuscular 
ketamine can cause a high incidence of PONV. 
 
Roback et al., in 2006 reported that vomiting in the emergency department was 
more common in the intramuscular ketamine group (26.3%), versus 11.9% in the 
intravenous ketamine group. 
 
In a study performed by Barr and Wynn (1992) 22% of children were nauseous 
and 15% vomited after procedural sedation with a combination of ketamine and 
fentanyl.  These findings highlight the importance side effects when using drugs 
for sedation. 
 
As sedation practitioners we need to use small doses of drugs, and titrate it to 
effect of applying discharge criteria.  The chi-squared results in Table 15 showed 
significant lack of homogeneity of the percentages for both drowsiness and severe 
swelling at the operation site. 
 
Our findings show the frequency and quality of side effects when using advanced 
sedation technique.  We however report a low incidence of side effects when we 
compare it with other studies in literature.  We therefore feel that the drugs that 
we used are safe for sedation practice. 
 
4.3 Haemodynamic Effects of Drugs used in a Clinical Study 
 
4.3.1 Introduction 
 
It is common knowledge that the use of combinations of drugs may cause 
unforeseen synergistic pharmacological effects.  This may cause respiratory 
and/or cardiovascular depression. 
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The sedation guidelines of the Scottish Intercollegiate Guidelines Network (2002) 
claim that sedative drug combinations should be avoided in children as they are 
often associated with deeper levels of sedation and with more adverse effects.  
This is not entirely correct as sedative combinations are often used (SASA, 2010).  
When sedative combinations are used carefully in children, titrated to effect, and 
administered by a trained sedation practitioner, we do not often see adverse 
events.  This was done in our study with no haemodynamically related adverse 
events. 
 
Propofol, a drug used for advanced sedation techniques, can cause a decrease in 
the following haemodynamic parameters, the following effects, 
 systolic and diastolic blood pressures,  
 respiratory rates,  
 oxygen saturation levels and  
 pulse rates (Bassett et al., 2003).  
 
The question is did we see this in our study?  A study by Roelofse, Joubert and 
Roelofse, (1996) showed a significant increase in blood pressures and pulse rates 
in children receiving ketamine and midazolam for sedation.  This may have been 
related to the level of anxiety and/or intrinsic sympathomimetic effects of 
ketamine. 
 
4.3.2 Objectives of the study 
 
In trying to demonstrate the safety of sedative agents used during sedation we need to 
look at the haemodynamic parameters; what do drugs do to the blood pressure and 
pulse rates?  The purpose of this study was to evaluate haemodynamic parameters 
such as pulse rates, systolic blood pressures when using an advanced sedation 
technique in patients for dental procedures. 
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4.3.3 Materials and Methods 
 
The sedation records of 335 patients for dental surgery were assessed for the 
period 2010 – 2011.  From 335 sedation records,  only 183 records were actually 
chosen and from this number 158 records were used for further analyses.  The 
following vital signs were continuously recorded on the sedation flow sheet 
during sedation and recovery; oxygen saturation levels, pulse rates and systolic 
blood pressure.  
 
A combination of four sedative/hypnotic, and analgesic drugs fentanyl (F), 
ketamine (K), midazolam (M) and propofol (P) were used.  Doses were 
administered intravenously according to the age and weight of the patients.  
Patients were selected and examined by the sedation practitioner.   
 
Patients were only discharged from the sedation facility when haemodynamically 
stable.  The following discharge criteria were used:  
 blood pressures and pulse rates 
 able to swallow and cough, 
 can walk without feeling faint, 
 no nausea and vomiting, 
 breathing unobstructed,  
 fully awake and aware, 
 no complications of the operation  
 
4.3.4 Statistical analysis of results 
 
Data was recorded in an EXCEL spreadsheet and statistical analysis was 
performed with statistical package R (R Core Team, 2014).    Means and standard 
deviations were obtained for the subgroups of patients defined by the drug 
combinations employed for them.  The statistical significance of group differences 
was examined using analysis of variance techniques and the Kruskal-Wallis rank 
test.  Graphs of means, with lower and upper limits useful for judging the 
significance of mean differences were constructed. 
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4.3.5 Results 
 
The following codes are used for the drugs: F = fentanyl, K = ketamine, M = 
midazolam, P = propofol. 
The drug combinations used for the 183 patients are listed in Table 18;  y=Yes, 
n=No.   
 
Table 18 gives the number of patients receiving the different drug combinations.  
For example the table shows that 35 patients received all four drugs during 
sedation, 58 patients received the two drugs ketamine and propofol.  
 
Table 18. Number of patients receiving the different drug combinations 
F K M P Frequency 
n n n n 2 
n y n n 1 
y y n n 1 
n n y n 5 
y n y n 2 
n y y n 2 
y y y n 1 
n n n y 4 
n y n y 58 
y y n y 51 
n n y y 1 
y n y y 6 
n y y y 14 
y y y y 35 
 
     
Because of the low frequencies at many of the drug combinations only those with 
frequencies greater than or equal to 10 were  considered for further analysis; there 
were four such groups,  namely,  KP (n=58),  FKP (n=51),  KMP (n=14),  FKMP 
(n=35).   
 
The variables with respect to which the four groups were compared are: Duration 
of sedation, Pulse rate and Systolic blood pressure. 
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 Duration of sedation 
 
Table 19 gives summary statistics of variable duration of sedation times for the 
four groups with the greatest numbers of patients.  
 
The columns labelled lower and upper aremean±1.4(SE), where SE is the 
standard error of the mean; the factor 1.4 is chosen such that non overlapping 
of the intervals demarcated by lower and upper indicate statistical significance 
at level approximately 0.05.  The lower limit at (nyyy)(20.74) is greater than 
the upper limit at (nyny)(10.22),  showing that the mean at (nyyy) is 
statistically significantly greater than the mean at (nyny). 
 
Table 19: Duration of sedation summary statistics 
Drug combination 
 F K M P Number Mean SD Lower Upper 
n y n y 58 9.45 4.20 8.68 10.22 
y y n y 51 14.73 14.03 11.97 17.48 
n y y y 14 27.50 18.05 20.74 34.26 
y y y y 35 51.71 25.52 45.67 57.75 
 
According to a Kruskal-Wallis test there are statistically significant differences 
between the four group locations (indicated by their means); Kruskal-Wallis 
chi-squared = 78.737, df = 3, p-value <0.0001. 
 
The data in Table 19 are represented graphically in Figure 10 showing mean 
values as dots with associated Lower and Upper limits.  The limit lower=mean-
1.4×SE, Upper=Mean +1.4×SE where SE is the standard error of the mean, 
SD/N1/2;  the factor 1.4 in the definition of the limits is chosen so that non-
overlap of two independent intervals indicates statistically significant 
difference of means at level approximately 0.05. 
 
Figure 10 shows some clear trends, for example, the mean Duration of sedation 
is substantially and statistically significantly greater with combination FKMP 
than with the other combinations.  The mean Duration of sedation is not 
significantly different between KP and FKP. 
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This is a significant finding for sedation practitioners. The use of 
polypharmacy regarding the combination of drugs, specifically FKMP, will 
cause a longer duration of sedation.  This has implications for safety, as well as 
the side effects profile during and after sedation. 
 
Figure 10. Duration of sedation for certain drug combinations 
 
 Pulse rate 
 
Table 20. Pulse rate summary statistics 
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n y y y 6 85.17 24.88 70.95 99.39 
y y y y 10 85.44 15.92 78.01 92.87 
n  y n y 46 106.33 16.59 102.90 109.75 
y y n y 38 108.11 15.92 104.48 111.72 
 
According to a Kruskal-Wallis test there are statistically significant differences 
between the four group locations (indicated by their means); Kruskal-Wallis 
chi-squared = 15.427, df = 3, p-value = 0.001.  
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The data in table 20 are presented graphically in Figure 11, which shows mean 
values as dots with associated lower and upper ±1.4 (SE) limits.  The graph 
shows that the mean pulse rates at (nyyy) (KMP) is significantly smaller than 
the means at (nyny) (KP) and (yyny) (FKP). 
 
It is noted that there was no tachycardia during sedation (pulse rates > 
120/min).  The results of the statistical analysis show that all patients were 
sedated at an acceptable level of consciousness where they were comfortable 
with no pain or side effects.  Combinations of a greater number of drugs clearly 
show that patients were more comfortable than when fewer drugs were used. 
 
Different combinations of drugs are used by other practitioners with a higher 
incidence of side effects.  The combinations of drugs we used look like an ideal 
combination for procedural sedation as our side-effect profile was very low.  
 
The important lesson from all the results is that sedation providers must be 
trained in procedural sedation as expected by all international sedation 
guidelines. 
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Figure 11. Drug combinations and pulse rate
 
 
 Systolic blood pressures end of procedure 
 
Table 21. Systolic End blood pressure summary statistics 
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n y y y 13 101.92 14.06 96.46 107.38 
y y n y 49 107.47 16.11 104.25 110.69 
n  y n y 57 109.09 16.72 105.99 112.19 
y y y y 35 118.03 19.13 113.50 122.55 
 
A Kruskal-Wallis test gives results:Kruskal-Wallis chi-squared = 10.253, df = 
3, p-value = 0.017, indicating statistically significant differences between 
group means. 
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The mean systolic blood pressure end at (yyyy) (FKMP) is significantly higher 
than the other three means (Table 21).  The data in Table 21 are represented 
graphically in Figure 12, which shows mean values as dots with associated 
confidence limits. 
 
It is difficult to explain the higher values of blood pressures when all four 
drugs were used.  It may have been a ketamine effect, although one would not 
expect this when using propofol with ketamine. 
 
In clinical terms the higher blood pressures are no reason for concerns about 
the safety of the patients. 
 
Figure 12. Drug combinations and systolic blood pressure end of 
procedure 
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4.3.6. Discussion 
 
It is reasonably safe to say that, with haemodynamic parameters so stable in this 
study, combinations of drugs can be safely used for procedural sedation. No 
incidences of hypotension or bradycardia or other complications were seen. 
 
As sedation practitioners we should be extremely careful when we use multiple 
drugs. Drug interactions always remain a possibility, which can be a threat to 
patient safety. Combining different drugs can easily lead to deeper levels of 
consciousness and even unconsciousness bordering on general anaesthesia.  
 
This study is a significant contribution to current knowledge on the use of 
combinations of drugs for procedural sedation.  Very few studies in the literature 
report on combinations of drugs for procedural sedation in children and adults. 
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CHAPTER 5:  CONCLUSIONS 
 
This study shows conclusively that procedural sedation can be managed and 
safely done outside the hospital environment, as an alternative for general 
anaesthesia for certain dental procedures. 
All international guidelines say that ASA I and II patients can be done outside the 
hospital setting in dental or medical rooms, facilities, and clinics.  This study was 
done in a clinic that is attached to the hospital, outside the hospital theaters.  
Paediatric sedation remains a controversial issue, in some countries. There are 
clinicians that feel that small children must at least be done in a dedicated clinic, 
or in hospital near operating theaters.  There are also clinicians that are 
uncomfortable about the use of multiple drugs for paediatric sedation.  Many of 
them feel that nitrous oxide sedation is the best option.  It is however not an 
option for longer and more invasive procedures in children. 
This research study shows that children can in fact be done safely outside the 
operating theater when multiple drugs are used.  It must however be done in 
premises that meet all the requirements for safe practice.  The sedation 
practitioner must also have the necessary postgraduate qualification in sedation.  
This is an extremely important research study and the results are crucial as far as 
an option for healthcare in developing countries.  Sub-Saharan Africa is a densely 
populated and resource poor subcontinent that provides unique challenges in 
patient care.  These challenges include a lack of facilities and staff for the 
performance of operative as well as non-operative procedures.  
 
In a survey on anaesthesia services in developing countries, the authors used a 
questionnaire to evaluate the difficulties in providing anaesthesia services in 
Africa.  This survey provides us with insight of the availability of anaesthesia 
services in other developing countries in Africa.  The survey results show that 23 
% of anaesthetists have the facilities to deliver safe anaesthesia to adults but only 
13 % have facilities to deliver safe anaesthesia to children.  The questionnaire 
identified shortages of personnel, drugs, equipment, and training as major factors 
influencing service delivery. These factors had neither been quantified nor 
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accurately described before.  Training was also highlighted as problematic, with 
few qualified physician anaesthetists amongst the anaesthesia providers.  Most of 
the non-anaesthetists had previously attended a training course with little 
supervised clinical training.  
 
Anaesthesia for procedures in children according to the results of the survey 
appears to be largely ketamine-based, mainly due to a “lack of disposable airway 
equipment such as tracheal tubes, facemasks and breathing circuits.” 
 
Ketamine is available in the majority of countries in Sub-Saharan Africa.  It is an 
extremely important and safe drug as it can provide anaesthesia, sedation, and 
analgesia.  Ketamine’s inherent safety profile allows it to be used safely for 
procedures outside the operating room, provided that standard safety requirements 
are adhered to. Ketamine, used intramuscularly and intravenously, is regarded by 
many as the “standard of care for the sedation of children in many developing 
countries”.  It can be used by both anaesthetists as well as “untrained personnel” 
for induction and maintenance of anaesthesia.  
 
Our research study support the view that ketamine can be used safely outside the 
operating theatre with exciting possibilities for Third World countries for 
procedures outside the operating theatre.  Sedation can be considered a reasonable 
alternative to general anaesthesia for certain surgical procedures in the Third 
World.  
 
Bearing in mind the common surgical conditions of childhood in developing 
countries in Africa, it becomes clear that there is a large potential market for 
sedation services, not only for dental procedures.  Common surgical conditions 
are encountered.  There are often not enough theater capacity, anaesthetists, and 
other healthcare personnel to provide general anaesthesia.  
 
Sedation will be an attractive option not only as far as costs are involved but also 
the availability of sedation providers.  We proved in this research study that 
sedation can be done safely, we however need to make a contribution to train 
sedation providers. 
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The cost issue and safety still remains a problem as some clinicians feel children 
must get sedation in-hospital.  The alternative would be to negotiate with private 
hospitals for a reduced fee under general anaesthesia or for that matter sedation in-
hospital.  This could lead to increased costs which will not be possible to all 
patients. 
We negotiated a reduced fee with a private hospital to look at the costs involved 
for dental procedures in children under general anaesthesia (Yasin-Harnekar, 
Carstens and Moola, 2012).  One hundred and four children aged 2 - 12 years 
were entered for this study, 9.2% were younger than 6yrs. This is the age group 
that clinicians are worried about when combinations of drugs are being used. We 
proved that children in this age group can be safely done under sedation outside 
the traditional operating theater. 
The objectives were to determine also the 
 the cost of dental treatment under general anaesthesia in a private facility 
where a reduced fee was negotiated. 
 The costs involved when only exodontia or restorations were done.  The 
assumption here was that the duration of anaesthesia will be shorter with 
exodontia, and the fee will be less than when restorations will be done, 
who usually take a longer time under general anaesthesia.  
 
The average time that children spent under general anaesthesia was 43.3 minutes.  
In this study 82% of children required both restorations and exodontia.   
The costs of general anaesthesia per patient for a 40-minute procedure were 
R4963.23. This amount includes a negotiated fee of R74.67/min, usually 
R150/min, for use of the theatre.  The current theatre fees in private practice are 
about 2- 2.5 times the above negotiated fee. 
The above shows that doing cases in-hospital are extremely costly.  It is not 
practical to go and negotiate reduced fees with hospital providers. We need 
another safe option. 
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It is important to understand that not all procedures can be done under sedation 
outside the hospital environment.  Two possible examples are the complexity of 
procedures, and the health status of the patients.  Sedation has however become an 
attractive alternative to general anesthesia for certain procedures in healthy 
patients.  
Two issues that make sedation an attractive alternative are the side-effect profile 
and patient satisfaction.  It is interesting that few studies are available that looked 
at this aspect of sedation.  One may ask why a reference to the side-effect profile?  
Has this got anything to do with safety?  It is clear that a high side-effect profile 
can contribute to an unsafe sedation technique for example, severe nausea and 
vomiting can cause numerous haemodynamic disturbances and dehydration.  
Patient satisfaction during and after sedation remains a very important component 
of safe sedation.  We are going to be judged by the patient.  
Patient preferences were evaluated in a study done after general anaesthesia in 
adult patients (Hill et al., 2002).  The results are quite interesting. Forty-nine 
percent of patients did not want nausea and vomiting, 27% wanted no pain, 13% 
wanted to be alert soon after the procedure, and 11% were concerned about 
additional costs under general anaesthesia. 
 
The reality concerning side-effects is much different after general anaesthesia as 
published in this study. The incidence of severe post-operative pain was 66%, 
post-operative nausea and vomiting 51%, and headaches 38%. 
 
Erasmus and Roelofse (2008) compared the side–effect profile of three different 
techniques often used for dental procedures, local anaesthesia, general anaesthesia 
and procedural sedation in 600 adult patients. 
This study also looked at the cost-effectiveness of general anaesthesia and 
sedation. This study showed conclusively a lower side-effect profile during and 
after sedation compared to general anaesthesia.  It was evident that more patients 
would prefer sedation in future if they had a choice; 99% of patients would prefer 
sedation as an option. 
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As far as costs are concerned 42% of patients complained that the anaesthetic fee 
was too high during general anaesthesia; only 3% of patients were uncomfortable 
about the sedation fee. 
The costs per time unit for the procedures were, 
 Sedation: R15.00 per minute 
 General anaesthesia: R75.00 per minute 
 
Lapere et al., (2015) looked at patient satisfaction in a study of 500 patients having 
sedation for dental procedures.  They feel that the clinician’s perspective of a good 
outcome and the patient’s experience of a satisfactory service are often two different 
end–points.   
 
The primary aim of their study was to assess the peri-operative experience of patients 
undergoing procedural sedation.  A secondary aim was to create a post-operative 
questionnaire which could be used as a measurement tool.  The questions could also 
be used as an audit to assist with adherence to quality assurance and clinical 
governance. 
 
The method used was to compile a questionnaire to assess the peri-operative aspect of 
procedural sedation.  Five hundred consecutive patients undergoing procedural 
sedation for dental-related procedures were asked to complete a questionnaire.  
Patients who did not complete it were excluded.  Ninety-eight per cent of the patients 
return the questionnaire and 489 questionnaires were evaluated. 
 
The results showed that ninety-three per cent of the patients expressed a good 
(7plus/10) overall experience of procedural sedation, and 92.6% indicated that they 
would recommend it to others. 
 
The study population showed a high level of satisfaction with their sedation 
experience. One of the questions was “did you feel safe” during sedation.  Very few 
patients felt unsafe.  The low side-effect profile, as in our study, must have 
contributed significantly to this very positive experience of sedation outside the 
operating theatre.  
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Our research study support the findings of the study by Lapere et al., (2015) that there 
is a high rate of patient satisfaction, and a low side-effect profile during and after 
sedation. 
 
In conclusion, we feel that we are part of Sub-Saharan Africa with all problems 
mentioned as far as provision of healthcare is concerned. This research study can 
make a crucial contribution to safe and cost-effective management of healthcare in 
Africa for procedures outside the operating theatre. 
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Appendix 1: Sedation Scoring System (SASA, 2015). 
 
 
Wilson Sedation Scale 
 
The level of consciousness can be assessed by using tools such as the Wilson 
Sedation Scale or the University of Michigan Sedation Scale 
 
Sc
or
e 
Description 
1 Fully awake and oriented 
2 Drowsy 
3 Eyes closed but rousable to command 
4 Eyes closed but rousable to mild physical stimulation (earlobe tug) 
5 Eyes closed but unrousable to mild physical stimulation 
 
 
 
University of Michigan Sedation Scale (UMMS) 
 
University of Michigan Sedation Scale (UMMS) 
0 Awake and alert  
1 Minimally sedated Patient drowsy, sleepy but rousable to verbal 
command 
2 Moderately sedated Patient may be sleeping, can be easily aroused by 
light tactile stimulation 
3 Deeply sedated Patient asleep, only rousable by significant 
physical stimulation, or repeated painful stimuli 
4 Unrousable No response with significant physical stimulation 
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Appendix 2: Basic equipment and drugs for procedural sedation and 
analgesia  (SASA, 2015). 
 
Devices to administer oxygen and assist with ventilation 
Oxygen and oxygen tubing Oxygen source must be reliable and able to provide at least 90% oxygen via a 
self-inflating positive pressure delivery system at 15 L/min for at least 60 
minutes 
Oxygen flow regulator  
Nasal prongs  
Venturi masks To deliver 40% oxygen 
Nebuliser and mask  
Self-inflating resuscitation bag with 
reservoir 
 
PEEP valve  
Catheter mount  
 
Airway devices and equipment 
Face masks Selection of sizes 
Laryngeal mask airways or similar 
supraglottic devices 
Sizes 3–5 
Range of cuffed endotracheal tubes Sizes 5–8 
Laryngoscope set Two handles with long and standard blades, and spare batteries and bulbs 
Water-soluble lubricant  
10 ml syringe for inflation of pilot balloon  
Tape or equivalent to secure endotracheal 
tube 
 
Oropharyngeal airways Sizes 3–5 
Nasopharyngeal airways Sizes 6 mm and 7 mm 
Stylets/introducers Appropriately sized for endotracheal tubes 
Magill forceps  
 
Monitoring equipment 
ECG monitor and cardiac defibrillator With conductive paste, chest paddles and razor 
Pulse oximeter  
Blood pressure monitoring device Non-invasive, with appropriately sized cuffs 
Stethoscope  
Thermometer  
Blood glucose testing device  
Selection of test tubes for blood 
biochemistry and full blood count 
 
Capnograph Nasal prongs with capnography line strongly recommended, but not 
compulsory 
 
Equipment with which to gain intravenous access 
Gloves  
Tourniquet  
Sterile gauze pads  
Alcohol skin wipes  
Intravenous cannulae 18–22 gauge 
Sterile needles  
Assortment of syringes 1 ml – 50 ml 
Sharps container  
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Tape or equivalent to secure intravenous 
cannulae 
 
 
Equipment for the accurate infusion of drugs and fluids 
Infusion pumps Intravenous fluid administration for simple sedation 
Syringe drivers Drug administration in advanced sedation 
Intravenous administration sets Must be compatible with infusion pumps 
Stickers for labelling syringes  
Drip stands  
Intravenous fluids Crystalloids and colloids 
 
Hardware and miscellaneous equipment 
Source of suction Including connection tubing 
Suction catheters Including catheters for suctioning endotracheal tubes, and Yankauer-type 
suction nozzles 
Therapeutic heat source  
Cardiac arrest board  
Appropriate lighting  
Operating surface that can be tilted  
Urinary catheters  
Nasogastric tubes  
Means of summoning emergency 
assistance 
 
South African Resuscitation Council 
algorithms 
Basic and advanced life support 
Procedural documentation  
 
Recommended emergency drugs 
Naloxone  
Flumazenil  
Adrenaline (at least 10 ampoules)  
Atropine or glycopyrrolate  
Ephedrine or phenylephrine (or other 
alpha-agonist) 
 
Lignocaine  
Glucose 50%  
Hydrocortisone, methylprednisolone or 
dexamethosone 
 
Promethazine (or other H1-antagonist)  
Nitroglycerine spray 
Nitroglycerine sprayeAspirin 
 
Aspirin  
Salbutamol  
Suxamethonium  
Intralipid  
Calcium-channel blocker e.g. nifedipine  
Beta blocker e.g. esmolol  
Selective alpha 1 adrenergic and non-
selective beta-adrenergic receptor blocker 
e.g. labetalol 
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Appendix 3: Medical History Questionnaire  (SASA, 2015). 
 
Name 
Sex Age Height Weight 
 
Do you suffer from, or is there a history of, the following? Tick either “yes” or “no” and, if any answer is “yes”, 
provide a detailed explanation. 
 
 YES NO 
1. Cardiovascular disease 
 High blood pressure, that is controlled   
 Heart failure   
 Heart valve lesion, rheumatic fever, or congenital heart disease   
 Dysrhythmia, palpitations (without exertion), or blackouts   
 Shortness of breath when lying down, or walking on a level surface   
If any answer is “yes”, please provide a detailed explanation: 
2. Central nervous system disorders 
 Epilepsy, fits (convulsions), or dizziness   
 Depression or psychosis   
If any answer is “yes”, please provide a detailed explanation: 
3. Blood disorders 
 Anaemia, sickle cell disorder, or thalassaemia   
 Abnormal bleeding associated with previous dental extractions, surgery or 
trauma, or do you bruise easily? 
  
If any answer is “yes”, please provide a detailed explanation: 
4. Blood clots 
 Episodes of thrombosis, or embolism of the legs or lungs   
If any answer is “yes”, please provide a detailed explanation: 
5. Respiratory disease 
 Do you smoke?   
 History of snoring   
 Lung disease, e.g. asthma, emphysema, or tuberculosis   
If any answer is “yes”, please provide a detailed explanation: 
6. Endocrine disorders 
 Diabetes mellitus   
If “yes”, please give details of medication and degree of control of blood sugar: 
 Thyroid   
 Porphyria, or other metabolic disorders   
If any answer is “yes”, please provide a detailed explanation: 
7. Liver disease 
 Hepatitis, or jaundice   
 Other liver disease   
If any answer is “yes”, please provide a detailed explanation: 
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 Yes No 
8. Kidney disease 
 Renal disease or disorders, or renal failure   
If the answer is “yes”, please provide a detailed explanation: 
9. Muscle disorders 
 Myopathy, dystrophy or progressive weakness, or malignant hyperthermia   
If the answer is “yes”, please provide a detailed explanation: 
10. Arthritis and orthopaedic problems   
If the answer is “yes”, please provide a detailed explanation: 
11. Stomach problems 
 Indigestion, heartburn, hernia, or ulcer   
If the answer is “yes”, please provide a detailed explanation: 
12. Hereditary disease   
If the answer is “yes”, please provide a detailed explanation: 
13. History of allergy in general, or allergic reactions to medications   
If the answer is “yes”, please provide a detailed explanation: 
14. Previous admission to hospital    
If the answer is “yes”, please provide a detailed explanation: 
15. Previous operations   
If the answer is “yes”, please provide a detailed explanation: 
16. History of taking medication or drugs, including herbal remedies and recreational drugs   
If the answer is “yes”, please provide a detailed explanation: 
17. Previous adverse or unpleasant reaction to anaesthesia   
If the answer is “yes”, please provide a detailed explanation: 
18. Infectious diseases   
If the answer is “yes”, please provide a detailed explanation: 
19. Airway problems      
If the answer is “yes”, please provide a detailed explanation: 
20. Failed sedation   
If the answer is “yes”, please provide a detailed explanation: 
21. Is there anything you would like to discuss, but would prefer not to write down?   
If the answer is “yes”, please contact your sedationist and discuss this with him/her before the date of your procedure 
 
 
……………………………………………………. …………………………………………….. 
Signature (Patient/Parent/Guardian) Date 
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Appendix 4: Sedation Monitoring C hart (SASA, 2015). 
 
DAYCARE SEDATION RECORD 
Date: Time in: Time out: 
Patient name: File No: ASA I II III IV V E 
DOB:  Age:  Weight:  
Procedure: Operator: 
Sedation list: 
Recovery nurse: 
Previous 
operations/sedation
/GA: 
Complications: 
Allergies: 
 
 
Last oral intake: Fluids: Solids: 
Premedication:  Given at: 
IV cannula size: 24G/22G/20G Site: 
IV fluids: Total fluids given: 
TIME                 
O2 %                 
N
2
O
 
% 
                
RR                 
EtCO2                 
SpO2                 
                 
B
P
 
2
0
0 
                
190                 
180                 
170                 
160                 
150                 
140                 
130                 
120                 
110                 
90                 
80                 
70                 
60                 
50                 
Heart 
rate: 
                
Drugs:                 
1                 
2                 
3                 
4                 
5                 
Medical history: 
Medication: 
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Appendix 5: Valid Consent To Sedation And Analgesia For Medical/Dental   
                      Procedures (SASA, 2015). 
 
I have been fully informed and I declare the following: 
1. I understand the nature of procedural sedation and analgesia, the purpose of the procedure and 
the risks involved. I understand that no guarantee can be given with regard to the results obtained.  
 
Procedural sedation and analgesia entails the administration of sedative and/or analgesic drugs 
to induce a reduced level of consciousness to such an extent that normal protective airway reflexes 
and spontaneous respiration are maintained, and cardiovascular function is unaffected. 
Procedural sedation and analgesia, together with regional/local anaesthesia, will put me/the 
patient in a relaxed state to make minor surgery possible. I understand that it is not a general 
anaesthetic and that I/the patient will not be unconscious, as I/the patient may have to respond to 
commands from the surgeon and/or the sedation practitioner. 
 
2. Unforeseen adverse events may arise during/after sedation that may require additional or 
different medications or treatment. I authorise the sedation practitioner to treat such adverse events 
according to his/her professional judgement: 
Possible adverse events include: 
• Unintended loss of consciousness 
• Drowsiness/dizziness 
• Shivering (4%) 
• Headaches (4%) 
• Post-sedation nausea and vomiting (0.7%) 
3. I give consent to the administration of such sedative and/or analgesic drugs as may be 
considered necessary or advisable by the sedation practitioner responsible for this service. 
4. I accept full and complete responsibility for actual and potential costs associated with 
procedural sedation and analgesia, and I accept full responsibility for the costs that have been 
explained to me. I agree to comply with the terms and conditions of payment. 
5. I have had the opportunity to ask questions and I have been given the opportunity to choose 
alternative methods of treatment e.g. general anaesthesia, or local anaesthesia without sedation, or 
the use of local anaesthesia with behaviour management techniques, to my satisfaction. 
6. I confirm that I have received written/oral instructions regarding the sedation, which I 
understand. I will abide by the pre- and postoperative instructions. I have completed a medical 
history questionnaire and have declared all drugs that I have taken during the last 6 months. 
 
I,………………………….……(patient/parent/guardian), of address 
 
…………………………………………………………...hereby authorise the following 
 
procedure/s to be performed on (name of patient) ……… 
 
utilising procedural sedation and analgesia/local anaesthesia techniques under direction of Dr 
…………………..…. 
 
Patient/parent/guardian signature …………………………… 
 
Witnesses: 1. …………………………... 2.………………………….. 
 
Practitioner’s declaration: I have explained the procedure of procedural sedation and analgesia, 
risks, alternatives and expectations to the patient/parent/guardian, and believe that he/she has been 
adequately informed and have consented. 
 
                 …………..……………………….   ……………………………… 
                          Practitioner’s signature            Date 
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Appendix 6: Post-operative  Record  and  Discharge Criteria Questionnaire 
(SASA, 2015). 
 
Name of patient: Date: 
 Yes No 
Are the blood pressure and heart rate stable?   
Can the patient swallow and cough?   
Can the patient walk without feeling dizzy or faint?   
Is the patient nauseous?   
Is the patient breathing comfortably and of normal colour?   
Is the patient awake and appropriate?   
Has the operative site been checked and is bleeding controlled?   
Have written postoperative instructions been given and explained to both patient and carer?   
Is the patient pain free?   
Have possible complications been explained?   
Has a prescription been given or medication dispensed?   
Is there a responsible adult to accompany the patient?   
Monitoring  
TIME                
O2 given                
RR                
SpO2                
Heart rate:                
Temperature:                
BP 190                
180                
170                
160                
150                
140                
130                
120                
110                
90                
80                
70                
60                
50                
40                
30                
Patient has been assessed and is deemed fit for discharge at:                       (time and date)  
Mode of transport home is:  
Signature of recovery nurse:  
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Appendix 7:  Pre- and post-sedation instructions for patients and carers 
(SASA, 2015). 
 
(Please read the instructions carefully, and then fill in your details.) 
 
Dear Patient/Parent/Guardian, 
 
You need to undergo a procedure/operation, and your doctor/dentist has chosen to 
do this under sedation. Please read the following information and instructions 
carefully. If anything is unclear, please contact your doctor/dentist at the 
following telephone numbers: 
Tel:……………………………………… 
 
Pre-sedation instructions 
 
 If you suffer from any medical condition or take any acute or chronic 
medicine, you will need to inform your doctor/dentist before the 
procedure/operation. A medical history questionnaire has been included; 
please complete this and return it to your doctor/dentist before the 
procedure/operation. This is an important document, as it will help us to 
decide whether you qualify for the sedation that will have to be given for 
the procedure/operation. If you feel sick or unwell, please call your 
doctor/dentist so that he/she can decide whether it is necessary to postpone 
the treatment. 
 Please wear comfortable clothes with loose-fitting sleeves. 
 Do not eat anything for at least 6 hours before the procedure/operation. 
Clear fluids may be taken up to 2 hours before. 
 If you take chronic medication, please do so on the day of the 
procedure/operation, after discussing this with your doctor/dentist. 
 Please arrive in good time for your appointment, at least 30 minutes 
beforehand. In some cases, your doctor/dentist may feel that you will 
benefit from premedication to reduce your anxiety and make you feel 
relaxed. If this is the case, your doctor/dentist may request that you come 
earlier for your appointment so you can take the premedication. 
 Please empty your bladder before the procedure/operation. 
 You must have an adult escort to accompany you home. The escort may 
remain with you until the sedation is underway and the procedure/operation 
is about to start. The escort will then be requested to leave the 
procedure/operation room. 
 There must be arrangements in place for you and the responsible escort to 
travel home by private car or taxi rather than public transport. 
 It may be necessary to put a drip/cannula in a vein in your hand or arm. 
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Post-sedation instructions (aftercare of the patient) 
 
 A responsible adult must take you home after the sedation, and you must 
remain in the company of a responsible adult for the remainder of the day. 
Sedation will not be given if you arrive without an escort.  
 You must not be in charge of other people. 
 You may not drive, operate equipment or participate in any other activities 
that require alertness or coordination (e.g. swimming, cycling, etc.) for at 
least 12 hours following the procedure/operation. 
 You must not climb heights (e.g. ladders, scaffolding). 
 If you are taking any regular medication, ask your doctor/dentist when you 
should take your next dose after the sedation. 
 You should not experience nausea or vomiting after sedation. If you do 
vomit, and this happens more than once, please contact your doctor/dentist. 
 Do not eat or drink if you are nauseous. Introduce any fluids or foods 
slowly after sedation. If you tolerate clear fluids, you may then progress 
onto solids. 
 If you have not passed urine within 6-8 hours of being discharged, please 
contact the doctor/dentist at the telephone numbers provided. 
 The sedation may result in amnesia (loss of memory). This is temporary, 
sometimes lasting for a few hours. 
 
I, ………………………….. , the undersigned, have read and understood these 
pre- and post-sedation instructions, and agree to contact the doctor/dentist if there 
is anything more that is not clear to me. 
 
              ………………………………………  ……………………………….. 
                Signature       Date 
 
We do not anticipate that you will have any adverse events or complications.  
Should you become concerned about anything, please contact: 
 
Dr …………………………   Telephone: …………………………… 
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Appendix 8: Pre-procedural Checklist (SASA, 2015). 
 
To be completed and signed by sedation practitioner 
 
Name: Date of birth: 
Age: Weight: 
Responsible doctor: Sedation practitioner: 
Procedure: Elective/Emergency/Urgent Name of accompanying adult: 
Has the patient completed a medical questionnaire? 
                            
Yes / No 
Has the patient been fully evaluated? 
                            
Yes / No 
Has the patient been physically examined and evaluated? 
Yes / No 
Sedation contraindication checklist 
Past sedation history  Yes / No 
Details: 
Previous sedation satisfactory  Yes / No 
Details: 
Airway problems  Yes / No 
Details: 
Previous failed sedation  Yes / No 
Reason: 
Raised intracranial  pressure  Yes / No 
Details: 
Previous complications  of sedation  Yes / No 
Details: 
Sleep apnoea  Yes / No Depressed level of consciousness  Yes / No 
Respiratory failure Yes / No Serious illness  Yes / No 
Details: 
Fasting time checklist 
Fasted for solids (including milk) From: (minimum 6 hours) 
Fasted for clear juice/water From: (minimum 2 hours) 
Significant underlying conditions (see medical questionnaire) 
Renal dysfunction  Yes / No Cardiac dysfunction  Yes / No 
Hepatic dysfunction  Yes / No Gastro-oesophageal reflux Yes / No 
Respiratory dysfunction  Yes / No Known allergies/drug  reactions  Yes / No 
Chronic medication  Yes / No 
If yes, have they been taken today?  Yes / No 
Specify chronic medication: 
Premedication and monitoring 
Premedication prescribed and by whom: Drug:  Dose: Time: Drug:  Dose: Time: 
Premedication administered: Yes / No Name of person who administered premedication: 
Name of sedation practitioner: 
Qualification: 
Name of qualified attendant: 
Equipment checklist (tick if present) 
Pulse oximeter  NIBP  ECG  
Airway equipment  Oxygen  Drugs  
Resuscitation equipment  Temperature probe  Circulatory support equipment  
 
 
Signature of sedation practitioner: …………………..……...Date: ………………………… 
 
Name of sedation practitioner (block letters):  …………………………………  
 
Qualification: ……………........... 
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Appendix 9: Drug dosing schedule for adults (SASA, 2015) and children 
(SASA, 2010). 
 
Dosing schedule of midazolam (Adults) (SASA guidelines, 2015). 
Route of 
administration 
Dose Recommended 
maximum dose 
Time to peak 
effect 
Duration of 
action 
Oral 0.25-0.5 mg/kg 7.5 mg 10-30 minutes 60 minutes* 
Buccal/sublingual 0.25mg-0.3mg 7.5 mg 10-15 minutes 20-60 minutes* 
Intravenous 0.05-0.1mg/kg to a 
maximum bolus of 2mg** 
3 mg 3-5 minutes 20-60 minutes* 
Rectal 0.5-0.75mg/kg  10-20 minutes 60 minutes* 
Intranasal 0.2-0.3 mg/kg 7.5mg 10-15 minutes 20-60 minutes 
*Dose-related 
**Titrate to effect and repeat dose every 10 minutes until desired level of sedation is achieved, or 
recommended maximum dose is reached,. 
***With elderly patients, it is advised that smaller intravenous doses must be titrated to effect 
(SASA guidelines, adults, 2015). 
 
Single agent dosing schedule of midazolam (Children) (SASA guidelines, 
2010). 
Route of 
administration 
Dose Recommended 
maximum dose 
Time to peak 
effect 
Duration of 
action 
Oral 0.25–0.5 mg/kg 7.5 mg 10–30 minutes 60 minutes* 
Sublingual 0.25–0.3 mg/kg 0.3 mg/kg 10–15 minutes 20-60 minutes* 
Intravenous 0.025–0.1 mg/kg** 1 mg 3–5 minutes 20-60 minutes* 
Rectal 0.5–0.75 mg/kg 1 mg/kg 10–20 minutes 60 minutes* 
Intranasal 0.2–0.3 mg/kg 0.3 mg/kg 10–15 minutes 60–120 minutes* 
When used in combination with other drugs, doses should be decreased and titrated to effect 
* Dose-related 
** Titrate to effect, repeat dose every five minutes until desired level of sedation achieved (SASA 
guidelines, children, 2010). 
 
Dosing schedule for bolus doses of propofol (Adults) (SASA guidelines, 2015). 
Dose Titration 
Onset of 
action 
Repeat 
dose 
Duration of 
action* 
Bolus 0.5 mg/kg over 3-5 
minutes* 
1 minute 45-90 seconds 0.5 mg/kg 5-8 minutes 
 
Dosing schedule for infusion of propofol for PSA (Adults) (SASA guidelines, 
2015). 
Intravenous infusion Target controlled infusion 
2–4 mg/kg/hour titrated to clinical 
effect 
Effect site concentration 1-2 μg/ml 
In elderly patients, commence infusion 
at 1–2 mg/kg/hour 
In elderly patients, recommended effect site 
concentration is0.6-0.8 μg/ml 
 
Single agent dosing schedule of propofol (Children) (SASA guidelines, 2010). 
Dose 
Onset of 
action 
Duration of 
action 
Repeat dose Titration interval 
0.3-0.5 mg/kg 45-90 
seconds 
5-8 minutes 0.5 mg/kg 1 minute 
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Dosing schedule of ketofol, consisting of ketamine 5mg/ml and propofol  
9 mg/ml (Children) (SASA guidelines, 2010). 
Route of 
administration 
Dose Onset of 
action 
Duration of 
action 
Repeat 
dose 
Titration 
interval 
Intravenous 0.05 
ml/kg* 
30 – 90 
seconds 
5-10 minutes 0.05 ml/kg 1-5 minutes 
*Ketamine 0.25 mg/kg and propofol 0.45 mg/kg. 
 
Dosing schedule of ketamine (Adult) (SASA guidelines, 2015). 
Route of 
administration 
Dose Onset of 
action 
Time to peak 
effect 
Duration of 
action* 
Oral 4–6 mg/kg as single agent, 
2 mg/kg  if used with other 
sedatives/ analgesics 
> 5 minutes 30 
minutes** 
4–6 hours 
Intravenous 0.5–1 mg/kg*** 1.5 minute 3–5 minutes 5-10 
minutes 
Intramuscular 2–4 mg/kg 2–5 minutes 20 minutes 30 
minutes** 
Rectal 4–6 mg/kg > 5 minutes 30 
minutes** 
30–120 
minutes** 
Nasal 5 mg/kg 10 minutes 20 minutes 1 hour 
*Duration of action is prolonged if ketamine is administered with other sedatives/analgesics 
**Dose-related 
***Titrate to effect and repeat dose every 10 minutes if necessary, until desired level of sedation 
achieved 
Dosing schedule of ketamine (Children) (SASA guidelines, 2010). 
Route of 
administration 
Dose Onset of 
action 
Time to peak 
effect 
Duration of 
action 
Sedation 
Oral 
6-10 mg/kg >5 minutes 30 minutes* 4-6 hours 
Intravenous 
(bolus) 
0.25-1 mg/kg** <1 minute 3-5 minutes 10-15 minutes 
Intravenous 
(infusion) 
0.5-1 mg/kg/hr*** <1 minute 3-5 minutes 10-15 minutes 
Intramuscular 
2-4 mg/kg 2-5 minutes 20 minutes 30-120 minutes* 
Rectal 
4-6 mg/kg >5 minutes 30 minutes* 30-120 minutes* 
Analgesia 
Oral 4-6 mg/kg >5 minutes 30 minutes* 4-6 hours 
Intravenous 
(infusion) 
0.15-0.3 mg/kg/hr <1 minute 3-5 minutes 15 minutes 
*     Dose-related 
**   Titrate to effect, repeating dose every three minutes until desired level of sedation achieved 
*** Infusion following bolus dose of 0.25-1 mg/kg 
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Dosing schedule of fentanyl (Adult) (SASA guidelines, 2015). 
Route of 
administration 
Dose Onset of 
action 
Time to 
peak effect 
Maximum 
dose 
Duration of 
action 
Oral/transmucosal 5-15µ/kg 15-30 
minutes 
30-45 
minutes 
 1 hour* 
Intravenous 0.25µ/kg** 3-6 minutes 2-3 minutes 2µ/kg 30 minutes* 
* Dose-related 
** Titrate to effect and repeat dose every 5 minutes, until desired level of analgesia is achieved 
 
Single agent dosing schedule of fentanyl (children) (SASA guidelines, 2010). 
Route of 
administration 
Dose Onset of 
action 
Time to 
peak effect 
Maximum 
dose 
Duration of 
action 
Oral/transmucosal 1-5µ/kg 15-30 minutes 30-45 
minutes 
5µ/kg 1 hour* 
Intravenous 0.25µ/kg** Immediate 3-8 minutes 2µ/kg 30 minutes* 
When used in combination with other drugs, doses should be decreased and titrated to effect 
* Dose-related 
** Titrate to effect, repeating dose every 3 minutes until desired level of analgesia achieved or 
maximum dose reached 
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Appendix 10: Post Conscious Sedation Recovery Audit Questionnaire (At 
home). 
 
 
 
POST CONSCIOUS SEDATION (CS) RECOVERY AUDIT QUESTIONNAIRE (AT HOME)
DATE: NAME: DoB: GENDER: M F
QUESTIONNAIRE DETAILS: STATE OF MIND ON DEPARTURE:
Explained to escort Yes No Happy Yes No
Escort agrees to complete questionnaire Yes No Indifferent Yes No
Weeping Yes No
Signature of parent/guardian/escort: Agitated Yes No
TIME OF DEPARTURE: MODE OF TRANSPORT HOME:
DURATION OF JOURNEY HOME: TIME OF ARRIVAL AT HOME:
DRUG SIDE-EFFECTS DURING JOURNEY: LEVEL OF SEDATION DURING JOURNEY
Nausea Yes No Awake + orIentated Yes No
Vomiting Yes No Drowsy Yes No
Headache Yes No Sleeping but easy to rouse Yes No
Blurred vision Yes No Sleeping but difficult to rouse Yes No
Restlessness Yes No
STATE OF MIND:   ON ARRIVAL      4 HOURS      8 HOURS     12 HOURS   24 HOURS
Happy Yes No Yes No Yes No Yes No Yes No
Indifferent Yes No Yes No Yes No Yes No Yes No
Weeping Yes No Yes No Yes No Yes No Yes No
Agitated Yes No Yes No Yes No Yes No Yes No
LEVEL OF SEDATION   ON ARRIVAL      4 HOURS      8 HOURS      12 HOURS    24 HOURS
Awake + orientated Yes No Yes No Yes No Yes No Yes No
Drowsy Yes No Yes No Yes No Yes No Yes No
Sleeping but easy to rouse Yes No Yes No Yes No Yes No Yes No
Sleeping but difficult to rouse Yes No Yes No Yes No Yes No Yes No
DRUG SIDE - EFFECTS   ON ARRIVAL      4 HOURS      8 HOURS      12 HOURS    24 HOURS
Nausea Yes No Yes No Yes No Yes No Yes No
Vomiting Yes No Yes No Yes No Yes No Yes No
Headache Yes No Yes No Yes No Yes No Yes No
Blurred vision Yes No Yes No Yes No Yes No Yes No
Restlessness Yes No Yes No Yes No Yes No Yes No
MEMORY OF PROCEDURES   ON ARRIVAL      4 HOURS      8 HOURS      12 HOURS    24 HOURS
Needle in arm or back of hand Yes No Yes No Yes No Yes No Yes No
Injection in the gum Yes No Yes No Yes No Yes No Yes No
Discomfort during treatment Yes No Yes No Yes No Yes No Yes No
Pain during treatment Yes No Yes No Yes No Yes No Yes No
Journey home Yes No Yes No Yes No Yes No Yes No
SATISFACTORY RATING SCALE: [POOR]                                                                                  1     2     3     4     5     6      7     8      9    10   [EXCELLENT]
WILL YOU OR YOUR CHILD CONSIDER HAVING CONSCIOUS SEDATION AGAIN IN FUTURE:  
YES OR NO  (WHY?) 
PLEASE FAX TO: (021) 931 2287
ATTENTION:  DR HA CARSTENS / PROF J ROELOFSE
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Appendix 11. Post Conscious Sedation Questionnaire (At home). 
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